MEMORIAL SLOAN-KETTERING CANCER CENTER: Form 990, tax year 2022
View the entire original 990 at ProPublica ↗
- Organization
- MEMORIAL SLOAN-KETTERING CANCER CENTER (EIN 91-2154267)
- Tax period
- 2022-01-01 to 2022-12-31
- Filed
- 2023-11-14
- IRS object ID
- 202303189349317180
- Schema version
- 2022v5.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule E
- Schedule F
- Schedule G
- Schedule H
- Schedule I
- Schedule J
- Schedule K
- Schedule K
- Schedule L
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2023-11-14T17:46:30-06:00 | ReturnTs |
| Tax Period End | 2022-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ERNST & YOUNG US LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 111 MONUMENT CIRCLE SUITE 4000 | AddressLine1Txt |
| City | INDIANAPOLIS | CityNm |
| State Abbreviation | IN | StateAbbreviationCd |
| ZIP | 46204 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2022-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 912154267 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Memorial Sloan-Kettering Cancer Center | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % KEVIN MALARKEY | InCareOfNm |
| Business Name Control | MEMO | BusinessNameControlTxt |
| Phone | 6462273092 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1275 York Avenue | AddressLine1Txt |
| City | New York | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10065 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | MICHAEL HARRINGTON | PersonNm |
| Person Title | EVP & CFO | PersonTitleTxt |
| Phone | 6462273722 | PhoneNum |
| Signature | 2023-11-13 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | MICHAEL | PersonFirstNm |
| Person Last | HARRINGTON | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | 999009999 | SSN |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | JENNIFER D RHODERICK | PreparerPersonNm |
| PTIN | P00395735 | PTIN |
| Phone | 3176817000 | PhoneNum |
| Preparation | 2023-11-13 | PreparationDt |
Additional Filer Information AdditionalFilerInformation
Trusted Customer TrustedCustomerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trusted Customer | 2 | TrustedCustomerCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2022 | TaxYr |
| Build TS | 2023-04-26 12:10:37Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | SELWYN M VICKERS MD | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1275 York Avenue | AddressLine1Txt |
| City | New York | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10065 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $8,031,562,034 | GrossReceiptsAmt |
| Group Return For Affiliates | Yes (true) | GroupReturnForAffiliatesInd |
| All Affiliates Included | Yes (true) | AllAffiliatesIncludedInd |
| Group Exemption | 3475 | GroupExemptionNum |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | www.mskcc.org | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Activity Or Mission | LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION , AND COST EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION. | ActivityOrMissionDesc |
| Voting Members Governing Body | 116 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 105 | VotingMembersIndependentCnt |
| Total Employee | 25794 | TotalEmployeeCnt |
| Total Volunteers | 438 | TotalVolunteersCnt |
| Total Gross UBI | $11,602,554 | TotalGrossUBIAmt |
| PY Contributions Grants | $817,480,000 | PYContributionsGrantsAmt |
| CY Contributions Grants | $693,029,020 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $5,422,024,000 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $5,673,295,000 | CYProgramServiceRevenueAmt |
| PY Investment Income | $534,488,000 | PYInvestmentIncomeAmt |
| CY Investment Income | $808,719,000 | CYInvestmentIncomeAmt |
| PY Other Revenue | $156,818,000 | PYOtherRevenueAmt |
| CY Other Revenue | $76,903,980 | CYOtherRevenueAmt |
| PY Total Revenue | $6,930,810,000 | PYTotalRevenueAmt |
| CY Total Revenue | $7,251,947,000 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $21,438,500 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $18,006,000 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $3,314,805,014 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $3,626,916,179 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $85,128,654 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $2,808,113,486 | PYOtherExpensesAmt |
| CY Other Expenses | $3,207,084,821 | CYOtherExpensesAmt |
| PY Total Expenses | $6,144,357,000 | PYTotalExpensesAmt |
| CY Total Expenses | $6,852,007,000 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $786,453,000 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $399,940,000 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $14,941,252,000 | TotalAssetsBOYAmt |
| Total Assets EOY | $13,998,385,000 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $5,116,410,000 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $5,257,167,000 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $9,824,842,000 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $8,741,218,000 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | THE MISSION OF MEMORIAL SLOAN-KETTERING CANCER CENTER IS TO LEAD IN THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF CANCER AND ASSOCIATED DISEASES THROUGH PROGRAMS OF EXCELLENCE IN RESEARCH, EDUCATION, OUTREACH AND COST-EFFECTIVE PATIENT CARE. LEADERSHIP IN PATIENT CARE: WE PLACE THE HIGHEST PRIORITY ON ADVANCING THE CARE OF CANCER PATIENTS THROUGH EARLY DETECTION, ACCURATE DIAGNOSIS, AND OPTIMAL TREATMENT. THESE THREE ELEMENTS LEAD TO THE MOST EFFECTIVE CANCER CARE POSSIBLE, WHICH IS ALSO THE MOST COST-EFFECTIVE CARE. WE STRIVE FOR EXCELLENCE IN ALL EXISTING AND EMERGING THERAPIES WITHOUT NEGLECTING THE NEED FOR ADVANCED APPROACHES IN PALLIATION. WE DELIVER THESE THERAPIES IN A CARING ENVIRONMENT THAT ENCOMPASSES PATIENTS AS WELL AS THEIR LOVED ONES. EXCELLENCE IN PATIENT CARE IS EXEMPLIFIED BY OUR MULTIDISCIPLINARY APPROACH, A CORE COMPETENCE OF OUR CENTER. WE ARE COMMITTED TO DEVELOPING OUTREACH PROGRAMS TO BRING EXCELLENCE IN CANCER CARE TO THE COMMUNITY. LEADERSHIP IN RESEARCH EX | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $5,536,139,759 | ExpenseAmt |
| Grant | $6,838,000 | GrantAmt |
| Revenue | $5,487,374,000 | RevenueAmt |
| Desc | PATIENT CARE: MEMORIAL SLOAN-KETTERING CANCER CENTER EXPERTS HAVE ESTABLISHED STANDARDS OF CARE AND TREATMENT PROTOCOLS FOR EACH TYPE AND STAGE OF CANCER. OUR PHYSICIANS HAVE AN EXTRAORDINARY DEPTH AND BREADTH OF EXPERIENCE IN DIAGNOSING AND TREATING ALL FORMS OF THE DISEASE, FROM THE MOST COMMON TO THE VERY RARE. EACH YEAR, THEY TREAT MORE THAN 400 DIFFERENT SUBTYPES OF CANCER. THIS LEVEL OF SPECIALIZATION CAN HAVE AN OFTEN-DRAMATIC EFFECT ON A PATIENT'S CHANCES FOR A CURE OR CONTROL OF THEIR CANCER. WHILE WE ARE KNOWN FOR OUR ADVANCED, INNOVATIVE THERAPIES, OUR PHYSICIANS ARE EQUALLY WELL REGARDED FOR THEIR COMPASSION AND CONCERN. OUR DISEASE MANAGEMENT PROGRAM FEATURES 16 MULTIDISCIPLINARY CANCER TEAMS. PATIENTS ARE TREATED BY AS MANY DIFFERENT SPECIALISTS AS ARE NEEDED FOR THEIR PARTICULAR TYPE OF DISEASE, INCLUDING SURGEONS, MEDICAL ONCOLOGISTS, RADIATION ONCOLOGISTS, RADIOLOGISTS, PATHOLOGISTS, PSYCHIATRISTS, AND NURSES. OUR PATHOLOGISTS HAVE UNSURPASSED EXPERTISE IN USING ADVANCED METHODS TO ACCURATELY DIAGNOSE CANCER. BECAUSE OF THEIR SOLE FOCUS ON CANCER, OUR SURGEONS USE SURGICAL TECHNIQUES THAT PRESERVE FORM AND FUNCTION. OUR RADIATION ONCOLOGISTS ARE DEVELOPING AND PUTTING INTO CLINICAL PRACTICE LEADING-EDGE TECHNOLOGIES AND TECHNIQUES IN RADIATION THERAPY. IN ADDITION, THE CENTER OFFERS A FULL RANGE OF PROGRAMS TO HELP PATIENTS AND FAMILIES THROUGHOUT ALL PHASES OF TREATMENT, INCLUDING SUPPORT GROUPS, GENETIC COUNSELING, HELP MANAGING CANCER PAIN AND SYMPTOMS, REHABILITATION, INTEGRATIVE MEDICINE SERVICES, AND ASSISTANCE IN NAVIGATING LIFE AFTER TREATMENT. THROUGHOUT THE COVID-19 PANDEMIC AND BEYOND MSKCC CONTINUES TO WORK TO PROTECT AND ASSIST THE PUBLIC. CURRENTLY, THE INSTITUTION IS ACTIVELY MAINTAINING A POSTURE OF PREVENTION AND SAFETY, WITH ITS EDUCATION PROGRAMS WHILE ENCOURAGING PERSONS TO WEAR THEIR MASKS AND ADHERE TO OTHER PREVENTIVE MEASURES LIKE GETTING BOOSTER SHOTS. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $929,342,368 | ExpenseAmt |
| Grant | $9,419,000 | GrantAmt |
| Revenue | $185,921,000 | RevenueAmt |
| Desc | RESEARCH: MEMORIAL SLOAN-KETTERING CANCER CENTER MAINTAINS ONE OF THE WORLD'S MOST DYNAMIC PROGRAMS OF CANCER RESEARCH. THE EXTRAORDINARY PATIENT CARE WE PROVIDE BENEFITS FROM OUR INNOVATIVE PROGRAMS IN BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH. RESEARCH AT SLOAN-KETTERING INSTITUTE IS DEDICATED TO UNDERSTANDING THE BIOLOGY OF CANCER THROUGH PROGRAMS IN CELL BIOLOGY, GENETICS, BIOCHEMISTRY, MOLECULAR BIOLOGY, STRUCTURAL BIOLOGY, COMPUTATIONAL BIOLOGY, IMMUNOLOGY, AND THERAPEUTICS. INVESTIGATORS AT SLOAN-KETTERING INSTITUTE COLLABORATE WITH MEMORIAL HOSPITAL PHYSICIAN-SCIENTISTS, A PARTNERSHIP THAT HELPS SPEED IMPORTANT RESEARCH FINDINGS FROM THE LABORATORY TO THE BEDSIDE, IN A PROCESS KNOWN AS TRANSLATIONAL RESEARCH. MEMORIAL SLOAN-KETTERING CANCER CENTER ALSO ACTIVELY INITIATES AND PARTICIPATES IN CLINICAL TRIALS TO IDENTIFY MORE EFFECTIVE CANCER THERAPIES, AND OUR PHYSICIANS ARE CURRENTLY LEADING MORE THAN 1,900 CLINICAL TRIALS FOR PEDIATRIC AND ADULT CANCERS. THE HUMAN ONCOLOGY AND PATHOGENESIS PROGRAM (HOPP) IS A FURTHER EFFORT TO INCREASE INSTITUTIONAL RESEARCH STRENGTH IN AREAS IMPORTANT IN CONTEMPORARY TRANSLATIONAL RESEARCH. HOPP IS DESIGNED TO MELD EVEN MORE THOROUGHLY THE CULTURES OF BASIC BIOLOGIC SCIENCE AND CLINICAL ONCOLOGY, AUGMENTING THE WORK CONDUCTED IN THE LABORATORIES OF MEMORIAL SLOAN-KETTERING CANCER CENTER'S PHYSICIAN-SCIENTISTS. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $237,089,883 | ExpenseAmt |
| Grant | $1,749,000 | GrantAmt |
| Desc | EDUCATION: EDUCATION IS A VITAL PART OF MEMORIAL SLOAN-KETTERING CANCER CENTER'S MISSION. OUR TRAINING PROGRAMS PREPARE PHYSICIANS AND SCIENTISTS FOR CAREERS IN THE BIOMEDICAL SCIENCES. OUR COLLABORATIONS WITH THE ROCKEFELLER UNIVERSITY, CORNELL UNIVERSITY, AND WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY OFFER PHD PROGRAMS IN CHEMICAL BIOLOGY, COMPUTATIONAL BIOLOGY AND MEDICINE, AND THE MEDICAL SCIENCES. THE CENTER ALSO PARTNERS WITH WEILL MEDICAL COLLEGE AND THE ROCKEFELLER UNIVERSITY TO OFFER A MD/PHD DEGREE FOR ASPIRING PHYSICIAN-SCIENTISTS. THE CENTER HAS A PHD PROGRAM IN CANCER BIOLOGY THROUGH ITS LOUIS V. GERSTNER, JR. GRADUATE SCHOOL OF BIOMEDICAL SCIENCES. THIS NOVEL PROGRAM HAS BEEN ENROLLING STUDENTS SINCE 2006 AND TRAINS BASIC LABORATORY SCIENTISTS TO WORK IN RESEARCH AREAS DIRECTLY RELEVANT TO CANCER AND OTHER HUMAN DISEASES. WE ALSO OFFER POSTGRADUATE CLINICAL FELLOWSHIPS TO TRAIN PHYSICIANS WHO SEEK SPECIAL EXPERTISE IN A PARTICULAR TYPE OF CANCER AND POSTGRADUATE RESEARCH FELLOWSHIPS THAT PROVIDE PHYSICIANS AND SCIENTISTS WITH ADVANCED LABORATORY RESEARCH TRAINING. WITH FACULTY APPOINTMENTS AT THE WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY, OUR CLINICAL STAFF ALSO TRAIN RESIDENTS AND MEDICAL STUDENTS. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $6,702,572,010 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (true) | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | Yes (true) | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | Yes (true) | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | false | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | false | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (true) | ConsolidatedAuditFinclStmtInd |
| School Operating | Yes (true) | SchoolOperatingInd |
| Foreign Office | Yes (true) | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | false | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | false | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (true) | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | Yes (true) | OperateHospitalInd |
| Audited Financial Stmt Att | Yes (true) | AuditedFinancialStmtAttInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | Yes (true) | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | Yes (true) | TaxExemptBondsInd |
| Invest Tax Exempt Bonds | false | InvestTaxExemptBondsInd |
| Escrow Account | false | EscrowAccountInd |
| On Behalf Of Issuer | false | OnBehalfOfIssuerInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | Yes (true) | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | Yes (true) | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | Yes (true) | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | Yes (true) | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (true) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | Yes (true) | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 1399 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 25794 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (true) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (true) | Form990TFiledInd |
| Foreign Financial Account | false | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (true) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (true) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | Yes (true) | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | false | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 116 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 105 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (true) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | Yes (true) | MembersOrStockholdersInd |
| Election Of Board Members | Yes (true) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | false | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AZ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | DE | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | DC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ID | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | LA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ME | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NE | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TX | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WY | StatesWhereCopyOfReturnIsFldCd |
| Other Website | Yes (X) | OtherWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | KEVIN MALARKEY | PersonNm |
| Phone | 6462272638 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1275 YORK AVENUE | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 100656007 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part VII | Yes (X) | InfoInScheduleOPartVIIInd |
Form990 Part VII Section A Form990PartVIISectionAGrp (56 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|
| CRAIG B THOMPSON MD | ||||||||
| PRESIDENT & CEO-UNTIL 9/22 | 50.0 | 0.0 | Yes (X) | Yes (X) | $7,914,850 | $0 | $206,110 | |
| JASON KLEIN | ||||||||
| SVP CHIEF INVESTMENT OFFICER | 50.0 | 0.0 | Yes (X) | $6,807,925 | $0 | $76,122 | ||
| MARK BILSKY MD | ||||||||
| ATTENDING-NEUROSURGERY | 50.0 | 0.0 | $3,351,870 | $0 | $60,126 | Yes (X) | ||
| BABAK MEHRARA MD | ||||||||
| CHIEF ATTENDING-SURGERY | 50.0 | 0.0 | $2,771,948 | $0 | $73,619 | Yes (X) | ||
| MICHAEL HARRINGTON | ||||||||
| EVP & CFO | 50.0 | 0.0 | Yes (X) | Yes (X) | $2,743,280 | $0 | $58,995 | |
| JULIO GARCIA AGUILAR MD | ||||||||
| CHIEF ATTENDING-SURGERY | 50.0 | 0.0 | $2,727,893 | $0 | $73,626 | Yes (X) | ||
| JEFFREY DREBIN MD | ||||||||
| CHAIRMAN ATTENDNING-SURGERY | 50.0 | 0.0 | $2,721,892 | $0 | $75,744 | Yes (X) | ||
| KATHRYN MARTIN | ||||||||
| EVP & COO | 50.0 | 0.0 | Yes (X) | Yes (X) | $2,433,536 | $0 | $72,953 | |
| MARTIN WEISER MD | ||||||||
| ATTENDING-SURGERY | 50.0 | 0.0 | $2,400,313 | $0 | $77,331 | Yes (X) | ||
| LISA DEANGELIS MD | ||||||||
| PHYSICAN IN CHIEF | 50.0 | 0.0 | Yes (X) | $2,153,086 | $0 | $71,882 | ||
| SIMON POWELL MD | ||||||||
| DIRECTOR MSKCC PROTON, INC. | 50.0 | 0.0 | Yes (X) | $1,982,898 | $0 | $61,212 | ||
| JOAN MASSAGUE PHD | ||||||||
| DIRECTOR | 50.0 | 0.0 | Yes (X) | $1,799,890 | $0 | $70,264 | ||
| KENNETH MANOTTI | ||||||||
| SVP DEVELOPMENT | 50.0 | 0.0 | Yes (X) | $1,530,627 | $0 | $66,002 | ||
| JORGE LOPEZ ESQ | ||||||||
| EVP GENERAL COUNSEL | 50.0 | 0.0 | Yes (X) | $1,517,979 | $0 | $76,896 | ||
| SELWYN VICKERS MD | ||||||||
| PRESIDENT & CEO EFF 9/22 | 50.0 | 0.0 | Yes (X) | Yes (X) | $1,366,363 | $0 | $59,052 | |
| ROXANNE TAYLOR | ||||||||
| SVP CHIEF MKT/COMM UNTIL 10/22 | 50.0 | 0.0 | Yes (X) | $1,359,028 | $0 | $32,394 | ||
| DEBRA BERNS ESQ | ||||||||
| SVP CHIEF RISK OFFICER | 50.0 | 0.0 | Yes (X) | Yes (X) | $1,273,673 | $0 | $43,731 | |
| KERRY BESSEY | ||||||||
| SVP CHIEF HR OFFICER | 50.0 | 0.0 | Yes (X) | $1,224,934 | $0 | $76,420 | ||
| FREDERICK GROVES | ||||||||
| EVP HOSPITAL ADMINISTRATION | 50.0 | 0.0 | Yes (X) | $1,055,906 | $0 | $60,743 | ||
| REMY EVARD | ||||||||
| EVP & CHIEF DIGIT OFF EFF 1/22 | 50.0 | 0.0 | Yes (X) | $974,374 | $0 | $52,056 | ||
| MARK SVENNINGSON | ||||||||
| SVP FINANCE | 50.0 | 0.0 | Yes (X) | Yes (X) | $944,682 | $0 | $60,966 | |
| MARGARET BURKE | ||||||||
| DIRECTOR, MSKCC PROTON, INC. | 50.0 | 0.0 | Yes (X) | $831,215 | $0 | $76,482 | ||
| ERIN MCDONOUGH | ||||||||
| SVP CH MKT/COMM OFF EFF 10/22 | 50.0 | 0.0 | Yes (X) | $767,961 | $0 | $41,344 | ||
| CAROLYN LEVINE ESQ | ||||||||
| DEPUTY GEN COUNSEL | 50.0 | 0.0 | Yes (X) | $571,052 | $0 | $47,037 | ||
| AMADOR CENTENO | ||||||||
| SVP REAL ESTATE DEVLP EFF 7/22 | 50.0 | 0.0 | Yes (X) | $382,805 | $0 | $25,626 | ||
| RICHARD I BEATTIE | ||||||||
| SEE SCH O | 6.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| IAN COOK | ||||||||
| SEE SCHEDULE O | 5.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| STANLEY F DRUCKENMILLER | ||||||||
| SEE SCHEDULE O | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| ANTHONY B EVNIN | ||||||||
| SEE SCHEDULE O | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| ROGER W FERGUSON | ||||||||
| SEE SCHEDULE O | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| HENRY A FERNANDEZ | ||||||||
| SEE SCHEDULE O | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| WILLIAM E FORD | ||||||||
| SEE SCHEDULE O | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| RICHARD N FOSTER | ||||||||
| SEE SCHEDULE O | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| STEPHEN FRIEDMAN | ||||||||
| SEE SCHEDULE O | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| ELLEN V FUTTER | ||||||||
| SEE SCHEDULE O | 4.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| LOUIS V GERSTNER JR | ||||||||
| SEE SCHEDULE O | 7.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| JONATHAN N GRAYER | ||||||||
| SEE SCHEDULE O | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| BENJAMIN W HEINEMAN JR | ||||||||
| SEE SCHEDULE O | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| WILLIAM HELMAN | ||||||||
| SEE SCHEDULE O | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| JEFFREY P JOHNSON | ||||||||
| SEE SCHEDULE O | 2.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| MARGARET KEANE | ||||||||
| SEE SCHEDULE O | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| MARIE-JOSEE KRAVIS | ||||||||
| SEE SCHEDULE O | 6.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| JAMIE C NICHOLLS | ||||||||
| SEE SCHEDULE O | 5.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| JAMES G NIVEN | ||||||||
| SEE SCHEDULE O | 5.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| BRUCE C RATNER | ||||||||
| SEE SCHEDULE O | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| CLIFTON S ROBBINS | ||||||||
| SEE SCHEDULE O | 4.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| ALEXANDER T ROBERTSON | ||||||||
| SEE SCHEDULE O | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| JAMES D ROBINSON III | ||||||||
| SEE SCHEDULE O | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| VIRGINIA M ROMETTY | ||||||||
| SEE SCHEDULE O | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| ALAN D SCHNITZER | ||||||||
| SEE SCHEDULE O | 5.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| STEPHEN C SHERRILL | ||||||||
| SEE SCHEDULE O | 5.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| PETER J SOLOMON | ||||||||
| SEE SCHEDULE O | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| JOHN R STRANGFELD | ||||||||
| SEE SCHEDULE O | 3.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| SCOTT M STUART | ||||||||
| SEE SCHEDULE O | 7.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| DOUGLAS A WARNER III | ||||||||
| SEE SCHEDULE O | 5.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| PETER A WEINBERG | ||||||||
| SEE SCHEDULE O | 2.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $53,609,980 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $1,696,733 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 10157 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| JGN CONSTRUCTION CORP | |||||
| 66-40 69TH STREET | MIDDLE VILLAGE | NY | 11379 | GENERAL CONSTRUCTION | $17,994,620 |
| WORTHINGTON ENERGY | |||||
| 445 HUTCHINSON AVENUE | COLUMBUS | OH | 43235 | GENERAL CONSTRUCTION | $12,386,154 |
| LEND LEASE US CONSTRUCTION | |||||
| 200 PARK AVENUE | NEW YORK | NY | 10166 | GENERAL CONSTRUCTION | $10,176,404 |
| MICHAEL ANTHONY CONTRACTING | |||||
| 161 RAILROAD AVENUE | NEW HYDE PARK | NY | 11040 | GENERAL CONSTRUCTION | $9,760,497 |
| BOSTON CONSULTING GROUP | |||||
| 10 HUDSON YARDS | NEW YORK | NY | 10001 | CONSULTING | $7,575,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 203 | CntrctRcvdGreaterThan100KCnt |
| Fundraising | $4,668,603 | FundraisingAmt |
| Government Grants | $234,270,000 | GovernmentGrantsAmt |
| All Other Contributions | $454,090,417 | AllOtherContributionsAmt |
| Noncash Contributions | $12,032,474 | NoncashContributionsAmt |
| Total Contributions | $693,029,020 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (2 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt |
|---|---|---|---|
| MEDICAL CARE | 622310 | $5,487,374,000 | $5,487,374,000 |
| NON-GOVERNMENT SPONSORED RESEARCH | 541711 | $185,921,000 | $185,921,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $5,673,295,000 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $101,754,000 | TotalRevenueColumnAmt |
| Unrelated Business Revenue | -$9,140,686 | UnrelatedBusinessRevenueAmt |
| Exclusion | $110,894,686 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $50,886,000 | TotalRevenueColumnAmt |
| Exclusion | $50,886,000 | ExclusionAmt |
Gross Rents GrossRentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $34,530,000 | RealAmt |
Less Rental Expenses LessRentalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $48,914,000 | RealAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | -$14,384,000 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$14,384,000 | TotalRevenueColumnAmt |
| Exclusion | -$14,384,000 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $1,436,750,818 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $729,785,818 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $706,965,000 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $706,965,000 | TotalRevenueColumnAmt |
| Exclusion | $706,965,000 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $257,980 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $4,668,603 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $915,216 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$657,236 | TotalRevenueColumnAmt |
| Exclusion | -$657,236 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gaming Gross Income | $0 | GamingGrossIncomeAmt |
| Gaming Direct Expenses | $0 | GamingDirectExpensesAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $0 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $0 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Other Revenue Misc OtherRevenueMiscGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | ExclusionExclusionAmt |
|---|---|---|---|
| CAFETERIA | 722212 | $5,971,000 | $5,971,000 |
| VENDOR DISCOUNTS | 561439 | $2,402,000 | $2,402,000 |
| SERVICES PROVIDED | 561439 | $8,048,000 | $8,048,000 |
Miscellaneous Revenue MiscellaneousRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $24,638,216 | TotalRevenueColumnAmt |
| Unrelated Business Revenue | $20,743,240 | UnrelatedBusinessRevenueAmt |
| Exclusion | $3,894,976 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $41,059,216 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $7,251,947,000 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $5,673,295,000 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $11,602,554 | UnrelatedBusinessRevenueAmt |
| Exclusion | $874,020,426 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $190,000 | TotalAmt |
| Program Services | $190,000 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $17,816,000 | TotalAmt |
| Program Services | $17,816,000 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $53,881,298 | TotalAmt |
| Program Services | $43,895,802 | ProgramServicesAmt |
| Management And General | $8,280,809 | ManagementAndGeneralAmt |
| Fundraising | $1,704,687 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $339,857 | TotalAmt |
| Program Services | $339,857 | ProgramServicesAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,818,671,871 | TotalAmt |
| Program Services | $2,774,494,764 | ProgramServicesAmt |
| Management And General | $9,704,701 | ManagementAndGeneralAmt |
| Fundraising | $34,472,406 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $171,254,434 | TotalAmt |
| Program Services | $167,933,714 | ProgramServicesAmt |
| Management And General | $1,432,337 | ManagementAndGeneralAmt |
| Fundraising | $1,888,383 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $403,610,015 | TotalAmt |
| Program Services | $395,461,980 | ProgramServicesAmt |
| Management And General | $1,211,891 | ManagementAndGeneralAmt |
| Fundraising | $6,936,144 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $179,158,704 | TotalAmt |
| Program Services | $175,674,177 | ProgramServicesAmt |
| Management And General | $1,502,993 | ManagementAndGeneralAmt |
| Fundraising | $1,981,534 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $16,810,050 | TotalAmt |
| Program Services | $13,642,953 | ProgramServicesAmt |
| Management And General | $3,136,479 | ManagementAndGeneralAmt |
| Fundraising | $30,618 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,296,023 | TotalAmt |
| Program Services | $1,161,649 | ProgramServicesAmt |
| Management And General | $133,545 | ManagementAndGeneralAmt |
| Fundraising | $829 | FundraisingAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $829,671 | TotalAmt |
| Program Services | $829,671 | ProgramServicesAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $10,807,219 | TotalAmt |
| Management And General | $10,807,219 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $127,029,471 | TotalAmt |
| Program Services | $117,230,332 | ProgramServicesAmt |
| Management And General | $1,115,844 | ManagementAndGeneralAmt |
| Fundraising | $8,683,295 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $37,659,039 | TotalAmt |
| Program Services | $34,749,079 | ProgramServicesAmt |
| Management And General | $183,223 | ManagementAndGeneralAmt |
| Fundraising | $2,726,737 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $375,152,704 | TotalAmt |
| Program Services | $350,047,444 | ProgramServicesAmt |
| Management And General | $3,836,005 | ManagementAndGeneralAmt |
| Fundraising | $21,269,255 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $125,452,124 | TotalAmt |
| Program Services | $123,770,674 | ProgramServicesAmt |
| Management And General | $659,825 | ManagementAndGeneralAmt |
| Fundraising | $1,021,625 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,620,867 | TotalAmt |
| Program Services | $6,620,867 | ProgramServicesAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $197,473,541 | TotalAmt |
| Program Services | $177,241,484 | ProgramServicesAmt |
| Management And General | $20,099,050 | ManagementAndGeneralAmt |
| Fundraising | $133,007 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $8,963,300 | TotalAmt |
| Program Services | $8,669,472 | ProgramServicesAmt |
| Management And General | $96,198 | ManagementAndGeneralAmt |
| Fundraising | $197,630 | FundraisingAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $14,307,251 | TotalAmt |
| Program Services | $13,414,650 | ProgramServicesAmt |
| Management And General | $293,324 | ManagementAndGeneralAmt |
| Fundraising | $599,277 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $122,812,813 | TotalAmt |
| Program Services | $122,812,813 | ProgramServicesAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $437,223,926 | TotalAmt |
| Program Services | $431,739,952 | ProgramServicesAmt |
| Management And General | $5,144,416 | ManagementAndGeneralAmt |
| Fundraising | $339,558 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $20,901,923 | TotalAmt |
| Program Services | $20,732,878 | ProgramServicesAmt |
| Management And General | $14,377 | ManagementAndGeneralAmt |
| Fundraising | $154,668 | FundraisingAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | FundraisingFundraisingAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|---|
| PHARMACEUTICALS | $1,416,883,903 | $1,416,883,903 | ||
| MEDICAL/SURGICAL SUPPLIES | $337,014,057 | $337,014,057 | ||
| EXPENSES OFFSETTING REVENUE | -$49,829,216 | -$48,914,000 | -$915,216 | |
| UBIT EXPENSE | $43,411 | $43,411 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | -$367,256 | TotalAmt |
| Program Services | -$882,162 | ProgramServicesAmt |
| Management And General | -$3,389,311 | ManagementAndGeneralAmt |
| Fundraising | $3,904,217 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,852,007,000 | TotalAmt |
| Program Services | $6,702,572,010 | ProgramServicesAmt |
| Management And General | $64,306,336 | ManagementAndGeneralAmt |
| Fundraising | $85,128,654 | FundraisingAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Joint Costs | Yes (X) | JointCostsInd |
Total Joint Costs TotalJointCostsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $13,332,009 | TotalAmt |
| Program Services | $4,685,726 | ProgramServicesAmt |
| Fundraising | $8,646,283 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $197,290,000 | BOYAmt |
| EOY | $327,081,000 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,324,503,000 | BOYAmt |
| EOY | $1,225,430,000 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $510,406,000 | BOYAmt |
| EOY | $535,537,000 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $623,746,000 | BOYAmt |
| EOY | $660,791,000 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $100,000 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $55,017,000 | BOYAmt |
| EOY | $76,446,000 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $126,425,000 | BOYAmt |
| EOY | $127,758,000 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $456,894,000 | BOYAmt |
| EOY | $624,529,000 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $9,104,634,000 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $4,586,070,000 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,412,330,000 | BOYAmt |
| EOY | $4,518,564,000 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,665,943,000 | BOYAmt |
| EOY | $3,596,839,000 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,504,522,000 | BOYAmt |
| EOY | $2,238,842,000 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,549,000 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $55,527,000 | BOYAmt |
| EOY | $66,568,000 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $14,941,252,000 | BOYAmt |
| EOY | $13,998,385,000 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,229,458,000 | BOYAmt |
| EOY | $1,088,723,000 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,999,605,000 | BOYAmt |
| EOY | $3,265,895,000 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $153,465,000 | BOYAmt |
| EOY | $115,325,000 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $733,882,000 | BOYAmt |
| EOY | $787,224,000 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,116,410,000 | BOYAmt |
| EOY | $5,257,167,000 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,106,650,000 | BOYAmt |
| EOY | $7,056,745,000 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,718,192,000 | BOYAmt |
| EOY | $1,684,473,000 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,824,842,000 | BOYAmt |
| EOY | $8,741,218,000 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $14,941,252,000 | BOYAmt |
| EOY | $13,998,385,000 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $399,940,000 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$1,613,299,000 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $129,735,000 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (true) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (true) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Hospital | Yes (X) | HospitalInd |
| IRS Written Determination | Yes (X) | IRSWrittenDeterminationInd |
| Supported Organizations | 4 | SupportedOrganizationsCnt |
Supported Org Information SupportedOrgInformationGrp (4 entries)
| EINEIN | Organization TypeOrganizationTypeCd | Governing Document ListedGoverningDocumentListedInd | SupportSupportAmt | Other SupportOtherSupportAmt |
|---|---|---|---|---|
| SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | ||||
| 131624182 | 4 | Yes (true) | $0 | $0 |
| MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASES | ||||
| 131624082 | 3 | Yes (true) | $0 | $0 |
| MEMORIAL SLOAN-KETTERING CANCER CENTER | ||||
| 131924236 | 3 | Yes (true) | $0 | $0 |
| LOUIS V GERSTNER JR GRADUATE SCHOOL OF BIOMEDICAL SCIENCES | ||||
| 202212588 | 2 | Yes (true) | $0 | $0 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Supported Organizations Total | 4 | SupportedOrganizationsTotalCnt |
| Support Sum | $0 | SupportSumAmt |
| Other Support Sum | $0 | OtherSupportSumAmt |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $591,422,434 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $468,105,011 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $446,134,773 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $790,884,000 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $693,051,939 | CurrentTaxYearAmt |
| Total | $2,989,598,157 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $591,422,434 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $468,105,011 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $446,134,773 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $790,884,000 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $693,051,939 | CurrentTaxYearAmt |
| Total | $2,989,598,157 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $142,463,179 | SubstantialContributorsTotAmt |
| Public Support Total170 | $2,847,134,978 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $190,676,000 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $123,653,294 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $129,384,000 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $154,206,000 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $152,633,000 | CurrentTaxYearAmt |
| Total | $750,552,294 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $3,740,150,451 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $20,140,473,782 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.76123 | PublicSupportCY170Pct |
| Public Support PY170 | 0.77077 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Form990 Sch A Supporting Org Form990SchASupportingOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Listed By Name Governing Doc | Yes (true) | ListedByNameGoverningDocInd |
| Suprt Org No IRS Determination | false | SuprtOrgNoIRSDeterminationInd |
| Supported Org Section C456 | false | SupportedOrgSectionC456Ind |
| Supported Org Not Organized US | false | SupportedOrgNotOrganizedUSInd |
| Organization Change Suprt Org | false | OrganizationChangeSuprtOrgInd |
| Support Non Supported Org | false | SupportNonSupportedOrgInd |
| Payment Substantial Contribtr | false | PaymentSubstantialContribtrInd |
| Loan Disqualified Person | false | LoanDisqualifiedPersonInd |
| Controlled Disqualified Prsn | false | ControlledDisqualifiedPrsnInd |
| Disqualified Prsn Controll Int | false | DisqualifiedPrsnControllIntInd |
| Disqualified Prsn Ownr Int | false | DisqualifiedPrsnOwnrIntInd |
| Excess Business Holdings Rules | false | ExcessBusinessHoldingsRulesInd |
| Excess Business Holdings | false | ExcessBusinessHoldingsInd |
| Contribution Controller | false | ContributionControllerInd |
| Contribution Family | false | ContributionFamilyInd |
| Contribution35 Controlled | false | Contribution35ControlledInd |
Form990 Sch A Type1 Suprt Org Form990SchAType1SuprtOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Power Appoint Majority Dir Trst | Yes (true) | PowerAppointMajorityDirTrstInd |
| Operate Benefit Non Suprt Org | false | OperateBenefitNonSuprtOrgInd |
Form990 Sch A Type3 Sprt Org All Form990SchAType3SprtOrgAllGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Timely Provided Documents | false | TimelyProvidedDocumentsInd |
| Officers Close Relationship | false | OfficersCloseRelationshipInd |
| Supported Org Voice Investment | false | SupportedOrgVoiceInvestmentInd |
Adjusted Net Income AdjustedNetIncomeGrp
Net ST Capital Gain Adj Net Incm NetSTCapitalGainAdjNetIncmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
Recoveries PY Distributions RecoveriesPYDistributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
Other Gross Income OtherGrossIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
Adjusted Gross Income AdjustedGrossIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
Production Income ProductionIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
Other Expenses OtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
Total Adjusted Net Income TotalAdjustedNetIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
Minimum Asset Amount MinimumAssetAmountGrp
Average Monthly FMV Of Sec AverageMonthlyFMVOfSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
Average Monthly Cash Balances AverageMonthlyCashBalancesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
FMV Other Non Exempt Use Asset FMVOtherNonExemptUseAssetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
Total FMV Of Non Exempt Use Asset TotalFMVOfNonExemptUseAssetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Discount Claimed | $0 | DiscountClaimedAmt |
Acquisition Indebtedness AcquisitionIndebtednessGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
Adjusted FMV Less Indebtedness AdjustedFMVLessIndebtednessGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
Cash Deemed Charitable CashDeemedCharitableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
Net Vl Non Exempt Use Assets NetVlNonExemptUseAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
Pct Of Net Vl Non Exempt Use Ast PctOfNetVlNonExemptUseAstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
Recoveries PY Distri Min Asset RecoveriesPYDistriMinAssetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
Total Minimum Asset TotalMinimumAssetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prior Year | $0 | PriorYearAmt |
Distributable Amount DistributableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| CY Adj Net Income Distributable | $0 | CYAdjNetIncomeDistributableAmt |
| CY Pct85 Adjusted Net Income | $0 | CYPct85AdjustedNetIncomeAmt |
| CY Total Min Ast Distributable | $0 | CYTotalMinAstDistributableAmt |
| CY Greater Adjusted Minimum | $0 | CYGreaterAdjustedMinimumAmt |
| CY Income Tax Imposed PY | $0 | CYIncomeTaxImposedPYAmt |
| CY Distributable As Adjusted | $0 | CYDistributableAsAdjustedAmt |
Distributions DistributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| CY Paid Accomplish Exempt Prps | $0 | CYPaidAccomplishExemptPrpsAmt |
| CY Pd In Excess Income Activity | $0 | CYPdInExcessIncomeActivityAmt |
| CY Administrative Expense Paid | $0 | CYAdministrativeExpensePaidAmt |
| Exempt Use Assets Acquis Paid | $0 | ExemptUseAssetsAcquisPaidAmt |
| Qualified Set Aside | $0 | QualifiedSetAsideAmt |
| CY Other Distributions | $0 | CYOtherDistributionsAmt |
| CY Total Annual Distributions | $0 | CYTotalAnnualDistributionsAmt |
| CY Distri Attentive Suprt Org | $0 | CYDistriAttentiveSuprtOrgAmt |
| CY Distributable As Adjusted | $0 | CYDistributableAsAdjustedAmt |
| CY Distribution Yr | 0 | CYDistributionYrRt |
Distribution Allocations DistributionAllocationsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| CY Distributable As Adjusted | $0 | CYDistributableAsAdjustedAmt |
| Underdistributions | $0 | UnderdistributionsAmt |
| Excess Distribution Cyov Yr5 | $0 | ExcessDistributionCyovYr5Amt |
| Excess Distribution Cyov Yr4 | $0 | ExcessDistributionCyovYr4Amt |
| Excess Distribution Cyov Yr3 | $0 | ExcessDistributionCyovYr3Amt |
| Excess Distribution Cyov Yr2 | $0 | ExcessDistributionCyovYr2Amt |
| Excess Distribution Cyov Yr1 | $0 | ExcessDistributionCyovYr1Amt |
| Total Excess Distribution Cyov | $0 | TotalExcessDistributionCyovAmt |
| Cyov Applied Underdistri PY | $0 | CyovAppliedUnderdistriPYAmt |
| Cyov Applied Underdistr CPY | $0 | CyovAppliedUnderdistrCPYAmt |
| Carryover PY Not Applied | $0 | CarryoverPYNotAppliedAmt |
| Excess Distribution Cyov | $0 | ExcessDistributionCyovAmt |
| CY Total Annual Distributions | $0 | CYTotalAnnualDistributionsAmt |
| CY Distrib App Underdistri PY | $0 | CYDistribAppUnderdistriPYAmt |
| Excess Distribution | $0 | ExcessDistributionAmt |
| Remaining Underdistri PY | $0 | RemainingUnderdistriPYAmt |
| Remaining Underdistri CY | $0 | RemainingUnderdistriCYAmt |
| Excess Distri Cyov To Next Yr | $0 | ExcessDistriCyovToNextYrAmt |
| Excess From Year5 | $0 | ExcessFromYear5Amt |
| Excess From Year4 | $0 | ExcessFromYear4Amt |
| Excess From Year3 | $0 | ExcessFromYear3Amt |
| Excess From Year2 | $0 | ExcessFromYear2Amt |
| Excess From Year1 | $0 | ExcessFromYear1Amt |
Form990 Schedule A Part VI Form990ScheduleAPartVIGrp (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SUPPORTED ORGANIZATIONS | SUPPORT FROM THE SUPPORTING ORGANIZATIONS RELATE PRINCIPALLY TO THE SHARING OF CERTAIN FACILITIES, EQUIPMENT, PERSONNEL COSTS, EDUCATION, INSURANCE AND ALLOCATIONS. AMOUNTS DUE TO OR DUE FROM AFFILIATES RESULTING FROM THESE SERVICES DO NOT BEAR INTEREST. |
| SUPPORTING ORGANIZATIONS | NAME OF SUPPORTING ORGANIZATION EIN TYPE S.K.I. REALTY 13-3389586 12a MSK INSURANCE US 83-0363317 12a MSKCC PROTON INC. 35-2397819 12a MSKCC PROPERTIES, LLC. 35-2464610 12a |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Grassroots Lobbying | TotalGrassrootsLobbyingGrp | |
| Total Direct Lobbying | TotalDirectLobbyingGrp | |
| Total Lobbying Expend | TotalLobbyingExpendGrp | |
| Other Exempt Purpose Expend | OtherExemptPurposeExpendGrp | |
| Total Exempt Purpose Expend | TotalExemptPurposeExpendGrp | |
| Lobbying Nontaxable Amount | LobbyingNontaxableAmountGrp | |
| Grassroots Nontaxable | GrassrootsNontaxableGrp | |
| Tot Lbbyng Grassroot Mns Non Tx | TotLbbyngGrassrootMnsNonTxGrp | |
| Tot Lbby Expend Mns Lbbyng Non Tx | TotLbbyExpendMnsLbbyngNonTxGrp | |
| Volunteers | false | VolunteersInd |
| Paid Staff Or Management | Yes (true) | PaidStaffOrManagementInd |
| Media Advertisements | false | MediaAdvertisementsInd |
| Mailings Members | false | MailingsMembersInd |
| Publications Or Broadcast | false | PublicationsOrBroadcastInd |
| Grants Other Organizations | false | GrantsOtherOrganizationsInd |
| Direct Contact Legislators | Yes (true) | DirectContactLegislatorsInd |
| Direct Contact Legislators | $423,176 | DirectContactLegislatorsAmt |
| Rallies Demonstrations | false | RalliesDemonstrationsInd |
| Other Activities | Yes (true) | OtherActivitiesInd |
| Other Activities | $406,495 | OtherActivitiesAmt |
| Total Lobbying Expenditures | $829,671 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | false | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | LOBBYING COSTS | FormAndLineReferenceDesc |
| Explanation | THE ORGANIZATION ENGAGES IN FEDERAL, STATE, AND LOCAL LOBBYING. THE CENTER'S FEDERAL LOBBYING EFFORT FOCUSES ON PATIENT CARE AND REIMBURSEMENT ISSUES. PATIENT CARE ADVOCACY INCLUDES ENSURING PATIENTS ARE ABLE TO ACCESS CLINICAL TRIALS AND CANCER HOSPITALS ARE ABLE TO EFFECTIVELY RESEARCH POTENTIAL TREATMENTS FOR CANCER AS WELL AS PREVENTATIVE AND PALLIATIVE MEASURES. THE CENTER ALSO SEEKS EQUITABLE REIMBURSEMENT FOR SERVICES RENDERED TO PATIENTS ENROLLED IN ENTITLEMENT PROGRAMS. FROM TIME TO TIME, THE CENTER WEIGHS IN ON OTHER FEDERAL LEGISLATION THAT IMPACTS CANCER CARE AND HOSPITALS IN GENERAL. THE CENTER'S STATE LOBBYING EFFORTS FOCUS ON ISSUES RELATING TO PATIENT CARE, PUBLIC HEALTH, AND HOSPITAL OPERATIONS. PATIENT CARE AND PUBLIC HEALTH ISSUES MAY INCLUDE ACCESS TO CARE AND CANCER PREVENTION AND SCREENING, INCLUDING AS PART OF STATE BUDGET LEGISLATION. OUR ADVOCACY ON HOSPITAL OPERATIONS CENTERS ON ISSUES RELATING TO PROFESSIONAL LICENSURE AND CONTINUING EDUCATION, SCOPE OF PRACTICE, HOSPITAL STAFFING, AND HEALTH AND SAFETY REQUIREMENTS. ON OCCASION, THE CENTER ENGAGES IN LOCAL LOBBYING ON ISSUES RANGING FROM BUILDING ORDINANCES TO RADIATION CONTROL. THE CENTER ALSO INCURS COSTS FOR FEDERAL, STATE, AND LOCAL LOBBYING BY ASSOCIATIONS AND OTHER ORGANIZATIONS OF WHICH IT IS A MEMBER. PART II-B LINE 1(I) OTHER ACTIVITIES LOBBYING PORTION OF DUES PAID IN 2022 GREATER NEW YORK HOSPITAL ASSOCIATION $ 279,443 AMERICAN HOSPITAL ASSOCIATION 39,234 HOSPITAL ASSOC. OF NEW YORK 30,150 ALLIANCE OF DEDICATED CANCER CTRS 53,200 OTHERS 4,468 TOTAL $ 406,495 | ExplanationTxt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Public Exhibition Amounts | ArtPublicExhibitionAmountsGrp | |
| Held Works Art | HeldWorksArtGrp | |
| Agent Trustee Etc | false | AgentTrusteeEtcInd |
| Incl Escrow Custodial Acct Liab | false | InclEscrowCustodialAcctLiabInd |
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $1,327,922,000 | BeginningYearBalanceAmt |
| Contributions | $26,784,000 | ContributionsAmt |
| Investment Earnings Or Losses | -$2,684,000 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $1,352,022,000 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $1,228,619,000 | BeginningYearBalanceAmt |
| Contributions | $96,214,000 | ContributionsAmt |
| Investment Earnings Or Losses | $3,089,000 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $1,327,922,000 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $1,208,893,000 | BeginningYearBalanceAmt |
| Contributions | $19,598,000 | ContributionsAmt |
| Investment Earnings Or Losses | $128,000 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $1,228,619,000 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $1,123,167,000 | BeginningYearBalanceAmt |
| Contributions | $59,460,000 | ContributionsAmt |
| Investment Earnings Or Losses | $26,266,000 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $1,208,893,000 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $869,056,000 | BeginningYearBalanceAmt |
| Contributions | $152,114,000 | ContributionsAmt |
| Investment Earnings Or Losses | $101,997,000 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $1,123,167,000 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.42820 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.57180 | PrmnntEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | false | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | false | EndowmentsHeldRelatedOrgInd |
Land LandGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $423,133,000 | OtherCostOrOtherBasisAmt |
| Book Value | $423,133,000 | BookValueAmt |
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $6,058,924,000 | OtherCostOrOtherBasisAmt |
| Depreciation | $2,661,581,000 | DepreciationAmt |
| Book Value | $3,397,343,000 | BookValueAmt |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $111,351,000 | OtherCostOrOtherBasisAmt |
| Depreciation | $99,748,000 | DepreciationAmt |
| Book Value | $11,603,000 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $2,405,480,000 | OtherCostOrOtherBasisAmt |
| Depreciation | $1,817,000 | DepreciationAmt |
| Book Value | $587,885,000 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $105,746,000 | OtherCostOrOtherBasisAmt |
| Depreciation | $7,146,000 | DepreciationAmt |
| Book Value | $98,600,000 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $4,518,564,000 | TotalBookValueLandBuildingsAmt |
| Financial Derivatives | FinancialDerivativesGrp | |
| Closely Held Equity Interests | CloselyHeldEquityInterestsGrp |
Other Securities OtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | PRIVATE EQUITY & VENTURE CAP. | Desc |
| Book Value | $2,238,842,000 | BookValueAmt |
| Method Valuation | F | MethodValuationCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Securities | $2,238,842,000 | TotalBookValueSecuritiesAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (8 entries)
| DescDesc | AmtAmt |
|---|---|
| POSTRETIREMENT OBLIGATIONS | $101,100,000 |
| INSURANCE RESERVES | $315,623,000 |
| DEFERRED COMPENSATION | $80,178,000 |
| ASSET RETIREMENT OBLIGATION | $39,209,000 |
| DEFERRED GIFT ANNUITY | $11,679,000 |
| OTHER LIABILITIES | $1,606,000 |
| ROYALTY INTEREST LIABILITY | $122,048,000 |
| THIRD PARTY SETTLEMENT | $115,781,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $787,224,000 | TotalLiabilityAmt |
| Total Rev Etc Audited Fincl Stmt | $5,664,638,216 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$1,613,299,000 | NetUnrealizedGainsInvstAmt |
| Other Revenue | $49,871,216 | OtherRevenueAmt |
| Revenue Not Reported | -$1,563,427,784 | RevenueNotReportedAmt |
| Revenue Subtotal | $7,228,066,000 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $23,881,000 | InvestmentExpensesNotIncldAmt |
| Revenue Not Reported Fincl Stmt | $23,881,000 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $7,251,947,000 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $6,878,496,216 | TotExpnsEtcAuditedFinclStmtAmt |
| Other Expenses Included | $50,370,216 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $50,370,216 | ExpensesNotReportedAmt |
| Expenses Subtotal | $6,828,126,000 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $23,881,000 | InvestmentExpensesNotIncld2Amt |
| Expenses Not Rpt Fincl Stmt | $23,881,000 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $6,852,007,000 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | USE OF ENDOWMENT FUNDS | FormAndLineReferenceDesc |
| Explanation | PERMANENT ENDOWMENT FUNDS ARE HELD BY THE ORGANIZATION IN PERPETUITY. INCOME EARNED ON THE FUND BALANCE IS USED TO SUPPORT THE OPERATIONS OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATED ORGANIZATIONS. PART XI LINE 2D RENTAL EXPENSES OFFSETS REVENUE $48,914,000 SPECIAL EVENTS EXPENSES OFFSETS REVENUE 915,216 MMPC REV - SEPERATE 990 42,000 TOTAL $49,871,216 PART XII LINE 2D RENTAL EXPENSES OFFSETS REVENUE $48,914,000 SPECIAL EVENTS EXPENSES OFFSETS REVENUE 915,216 MMPC EXP - SEPERATE 990 541,000 TOTAL $50,370,216 FIN 48 - LIABILITY FOR UNCERTAIN TAX POSITIONS A FIN 48 FOOTNOTE DISCLOSURE, RELATING TO THE ACCOUNTING FOR INCOME TAXES, WAS NOT REQUIRED BECAUSE THERE WAS NO MATERIAL IMPACT ON THE INSTITUTION'S FINANCIAL STATEMENTS. | ExplanationTxt |
Schedule E IRS990ScheduleE
| Field | Value | IRS element (for citing) |
|---|---|---|
| Nondiscriminatory Policy Stmt | Yes (true) | NondiscriminatoryPolicyStmtInd |
| Policy Stmt In Brochures Etc | Yes (true) | PolicyStmtInBrochuresEtcInd |
| Plcy Pblczd Via Broadcast Media | Yes (true) | PlcyPblczdViaBroadcastMediaInd |
| Maintain Racial Comp Recs | Yes (true) | MaintainRacialCompRecsInd |
| Maintain Scholarships Recs | Yes (true) | MaintainScholarshipsRecsInd |
| Maintain Cpy Of Brochures Etc | Yes (true) | MaintainCpyOfBrochuresEtcInd |
| Maintain Cpy Of All Sol | Yes (true) | MaintainCpyOfAllSolInd |
| Discriminate Race Stdnts Rghts | false | DiscriminateRaceStdntsRghtsInd |
| Discriminate Race Admiss Plcy | false | DiscriminateRaceAdmissPlcyInd |
| Discriminate Race Emplm Fculty | false | DiscriminateRaceEmplmFcultyInd |
| Discriminate Race Schs | false | DiscriminateRaceSchsInd |
| Discriminate Race Educ Plcy | false | DiscriminateRaceEducPlcyInd |
| Discriminate Race Use Of Fclts | false | DiscriminateRaceUseOfFcltsInd |
| Discriminate Race Athlt Prog | false | DiscriminateRaceAthltProgInd |
| Discriminate Race Other Acty | false | DiscriminateRaceOtherActyInd |
| Government Financial Aid Rcvd | false | GovernmentFinancialAidRcvdInd |
| Government Financial Aid Rvkd | false | GovernmentFinancialAidRvkdInd |
| Compliance With Rev Proc7550 | Yes (true) | ComplianceWithRevProc7550Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | NONDISCRIMINATORY POLICY | FormAndLineReferenceDesc |
| Explanation | THE SCHOOL'S NONDISCRIMINATORY POLICY IS PUBLICIZED ON ITS WEB SITE: https://www.sloankettering.edu/gerstner/admissions/requirements ALL APPLICANTS TO THE LOUIS V. GERSTNER JR., GRADUATE SCHOOL OF BIOMEDICAL SCIENCES ARE CONSIDERED ON THE BASIS OF MERIT. THE SCHOOL DOES NOT DISCRIMINATE ON THE BASIS OF GENDER, RACE, COLOR, CREED, RELIGION, AGE, NATIONAL ORIGIN, DISABILITY, VETERAN STATUS, MARITAL STATUS, SEXUAL ORIENTATION, OR CITIZENSHIP STATUS IN ACCORDANCE WITH INSTITUTIONAL POLICY AND IN COMPLIANCE WITH THE REQUIREMENTS OF THE CIVIL RIGHTS ACT, THE EDUCATION AMENDMENTS, THE REHABILITATION ACT, THE AGE DISCRIMINATION ACT, AND THE AMERICANS WITH DISABILITIES ACT. EXCISE TAX ON NET INVESTMENT INCOME THE LOUIS V GERSTNER JR, GRADUATE SCHOOL OF BIOMEDICAL SCIENCES DOES NOT MEET THE CRITERIA OF SECTION 4968 AND, THEREFORE, IS NOT SUBJECT TO THE EXCISE TAX ON NET INVESTMENT INCOME. | ExplanationTxt |
Schedule F IRS990ScheduleF
Account Activities Outside US AccountActivitiesOutsideUSGrp (30 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| North America | 0 | 1 | Program Services | PATIENT CARE SUPPORT | $360,896 |
| Middle East and North Africa | 0 | 2 | Program Services | PATIENT CARE SUPPORT | $466,383 |
| Middle East and North Africa | 0 | 2 | Program Services | ADMIN SUPPORT | $310,878 |
| Europe (Including Iceland and Greenland) | 0 | 6 | Program Services | ADMIN SUPPORT | $855,047 |
| Europe (Including Iceland and Greenland) | 0 | 4 | Program Services | RESEARCH SUPPORT | $291,879 |
| East Asia and the Pacific | 0 | 1 | Program Services | RESEARCH SUPPORT | $59,710 |
| South Asia | 0 | 1 | Program Services | ADMIN SUPPT CONFRENCES | $8,108 |
| EUROPE | 0 | 17 | Program Services | ADMIN SUPPT CONFRENCES | $58,336 |
| Middle East and North Africa | 0 | 1 | Program Services | ADMIN SUPPT CONFRENCES | $4,252 |
| North America | 0 | 2 | Program Services | ADMIN SUPPT CONFRENCES | $1,600 |
| South Asia | 0 | 3 | Program Services | PATIENT CARE CONFRENCE | $28,226 |
| EUROPE | 0 | 81 | PROGRAM SERVICES | PATIENT CARE CONFRENCE | $592,222 |
| Middle East and North Africa | 0 | 5 | Program Services | PATIENT CARE CONFRENCE | $35,767 |
| North America | 0 | 22 | Program Services | PATIENT CARE CONFRENCE | $37,175 |
| East Asia and the Pacific | 0 | 8 | Program Services | PATIENT CARE CONFRENCE | $109,440 |
| Sub-Saharan Africa | 0 | 16 | Program Services | PATIENT CARE CONFRENCE | $90,787 |
| South America | 0 | 6 | Program Services | PATIENT CARE CONFRENCE | $14,022 |
| Central America and the Caribbean | 0 | 2 | Program Services | PATIENT CARE CONFRENCE | $1,091 |
| South Asia | 0 | 1 | PROGRAM SERVICES | RESEARCH CONFRENCES | $5,129 |
| EUROPE | 0 | 57 | PROGRAM SERVICES | RESEARCH CONFRENCE | $219,158 |
| Middle East and North Africa | 0 | 9 | PROGRAM SERVICES | RESEARCH CONFRENCE | $21,861 |
| North America | 0 | 18 | PROGRAM SERVICES | RESEARCH CONFRENCE | $18 |
| East Asia and the Pacific | 0 | 6 | PROGRAM SERVICES | RESEARCH CONFRENCE | $48,415 |
| Sub-Saharan Africa | 0 | 4 | PROGRAM SERVICES | RESEARCH CONFRENCE | $5,793 |
| EUROPE | 0 | 7 | PROGRAM SERVICES | EDUCATIONAL CONFRENCE | $26,646 |
| Middle East and North Africa | 0 | 2 | PROGRAM SERVICES | EDUCATIONAL CONFRENCE | $2,539 |
| North America | 0 | 3 | PROGRAM SERVICES | EDUCATIONAL CONFRENCE | $2,016 |
| Central America and the Caribbean | 0 | 0 | INVESTMENTS | $2,229,479,449 | |
| Middle East and North Africa | 0 | 0 | INVESTMENTS | $43,044,057 | |
| Europe (Including Iceland and Greenland) | 0 | 0 | INVESTMENTS | $36,536,295 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 178 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 109 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 287 | TotalEmployeeCnt |
| Subtotal Spent | $3,324,728 | SubtotalSpentAmt |
| Continuation Spent | $2,309,392,467 | ContinuationSpentAmt |
| Total Spent | $2,312,717,195 | TotalSpentAmt |
| Transfer To Foreign Corp | Yes (true) | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | Yes (true) | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | Yes (true) | PassiveForeignInvestmestCoInd |
| Foreign Partnership | Yes (true) | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | FOREIGN GRANTS AND INVESTMENTS | FormAndLineReferenceDesc |
| Explanation | MSKCC DOES NOT MAKE GRANTS OR USE GRANT MONEY OUTSIDE OF THE UNITED STATES VALUES SHOWN IN COLUMN F ARE THE MARKET VALUES FOR THE INVESTMENTS AT DECEMBER 31. | ExplanationTxt |
Schedule G IRS990ScheduleG
| Field | Value | IRS element (for citing) |
|---|---|---|
| All States | All States | AllStatesCd |
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | Spring Ball | Event1Nm |
| Gross Receipts Event1 | $2,443,877 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $2,366,377 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $77,500 | GrossRevenueEvent1Amt |
| Food And Beverage Event1 | $97,747 | FoodAndBeverageEvent1Amt |
| Entertainment Event1 | $62,400 | EntertainmentEvent1Amt |
| Other Direct Expenses Event1 | $129,569 | OtherDirectExpensesEvent1Amt |
| Event2 | Winter Lunch | Event2Nm |
| Gross Receipts Event2 | $790,255 | GrossReceiptsEvent2Amt |
| Charitable Contri Event2 | $753,630 | CharitableContriEvent2Amt |
| Gross Revenue Event2 | $36,625 | GrossRevenueEvent2Amt |
| Food And Beverage Event2 | $57,288 | FoodAndBeverageEvent2Amt |
| Other Direct Expenses Event2 | $37,999 | OtherDirectExpensesEvent2Amt |
| Other Events Total | 4 | OtherEventsTotalCnt |
| Gross Receipts Other Events | $1,692,451 | GrossReceiptsOtherEventsAmt |
| Charitable Contri Other Events | $1,548,596 | CharitableContriOtherEventsAmt |
| Gross Revenue Other Events | $143,855 | GrossRevenueOtherEventsAmt |
| Rent Fclty Costs Other Events | $221,457 | RentFcltyCostsOtherEventsAmt |
| Food And Beverage Other Events | $127,553 | FoodAndBeverageOtherEventsAmt |
| Entertainment Other Events | $8,000 | EntertainmentOtherEventsAmt |
| Oth Direct Expnss Other Events | $173,203 | OthDirectExpnssOtherEventsAmt |
| Gross Receipts Total | $4,926,583 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $4,668,603 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $257,980 | GrossRevenueTotalEventsAmt |
| Rent Fclty Costs Total Events | $221,457 | RentFcltyCostsTotalEventsAmt |
| Food And Beverage Total Events | $282,588 | FoodAndBeverageTotalEventsAmt |
| Entertainment Total Events | $70,400 | EntertainmentTotalEventsAmt |
| Oth Direct Expnss Total Events | $340,771 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $915,216 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | -$657,236 | NetIncomeSummaryAmt |
Schedule H IRS990ScheduleH
| Field | Value | IRS element (for citing) |
|---|---|---|
| Financial Assistance Policy | Yes (true) | FinancialAssistancePolicyInd |
| Written Policy | Yes (true) | WrittenPolicyInd |
| All Hospitals Policy | Yes (X) | AllHospitalsPolicyInd |
| FPG Reference Free Care | Yes (true) | FPGReferenceFreeCareInd |
Free Care Oth Percentage FreeCareOthPercentageGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | Yes (X) | OtherInd |
| Free Care Other | 500. | FreeCareOtherPct |
| Field | Value | IRS element (for citing) |
|---|---|---|
| FPG Reference Discounted Care | Yes (true) | FPGReferenceDiscountedCareInd |
Discounted Care Oth Percentage DiscountedCareOthPercentageGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | Yes (X) | OtherInd |
| Discounted Care Other | 500. | DiscountedCareOtherPct |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Free Care Medically Indigent | Yes (true) | FreeCareMedicallyIndigentInd |
| Financial Assistance Budget | Yes (true) | FinancialAssistanceBudgetInd |
| Expenses Exceed Budget | Yes (true) | ExpensesExceedBudgetInd |
| Unable To Provide Care | false | UnableToProvideCareInd |
| Annual Community Bnft Report | Yes (true) | AnnualCommunityBnftReportInd |
| Report Publically Available | Yes (true) | ReportPublicallyAvailableInd |
Financial Assistance At Cost Typ FinancialAssistanceAtCostTyp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $16,789,102 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $16,789,102 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00250 | TotalExpensePct |
Unreimbursed Medicaid UnreimbursedMedicaidGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $343,806,877 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $108,260,224 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $235,546,653 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.03440 | TotalExpensePct |
Total Financial Assistance Typ TotalFinancialAssistanceTyp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $360,595,979 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $108,260,224 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $252,335,755 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.03690 | TotalExpensePct |
Community Health Services CommunityHealthServicesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $15,586,011 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $312,398 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $15,273,613 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00220 | TotalExpensePct |
Health Professions Education HealthProfessionsEducationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $237,089,883 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $55,705,708 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $181,384,175 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.02650 | TotalExpensePct |
Subsidized Health Services SubsidizedHealthServicesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $2,164,099 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $2,164,099 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00030 | TotalExpensePct |
Research ResearchGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $755,896,061 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $396,020,798 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $359,875,263 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.05250 | TotalExpensePct |
Cash And In Kind Contributions CashAndInKindContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $324,601 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $324,601 | NetCommunityBenefitExpnsAmt |
Total Other Benefits TotalOtherBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $1,011,060,655 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $452,038,904 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $559,021,751 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.08150 | TotalExpensePct |
Total Community Benefits TotalCommunityBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $1,371,656,634 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $560,299,128 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $811,357,506 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.11840 | TotalExpensePct |
Environmental Improvements EnvironmentalImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $18,733 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $18,733 | NetCommunityBenefitExpnsAmt |
Coalition Building CoalitionBuildingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $91,210 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $91,210 | NetCommunityBenefitExpnsAmt |
Health Improvement Advocacy HealthImprovementAdvocacyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $1,667,595 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $1,667,595 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00020 | TotalExpensePct |
Workforce Development WorkforceDevelopmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $91,347 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $91,347 | NetCommunityBenefitExpnsAmt |
Total Communtity Building Acty TotalCommuntityBuildingActyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $1,868,885 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $1,868,885 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00020 | TotalExpensePct |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bad Debt Expense Reported | false | BadDebtExpenseReportedInd |
| Bad Debt Expense | $83,522,149 | BadDebtExpenseAmt |
| Bad Debt Expense Attributable | $1,779,915 | BadDebtExpenseAttributableAmt |
| Reimbursed By Medicare | $1,559,468,018 | ReimbursedByMedicareAmt |
| Cost Of Care Reimbursed By Medcr | $2,165,604,093 | CostOfCareReimbursedByMedcrAmt |
| Medicare Surplus Or Shortfall | -$606,136,075 | MedicareSurplusOrShortfallAmt |
Costing Methodology Used CostingMethodologyUsedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cost To Charge Ratio | Yes (X) | CostToChargeRatioInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Written Debt Collection Policy | Yes (true) | WrittenDebtCollectionPolicyInd |
| Financial Assistance Prvsn | Yes (true) | FinancialAssistancePrvsnInd |
| Hospital Facilities | 1 | HospitalFacilitiesCnt |
Hospital Facilities HospitalFacilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Facility | 1 | FacilityNum |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MEMORIAL HOSP FOR CANCER & ALLIED DIS | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1275 YORK AVENUE | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10065 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Website Address | www.mskcc.org | WebsiteAddressTxt |
| State License | 7002020H | StateLicenseNum |
| Licensed Hospital | Yes (X) | LicensedHospitalInd |
| General Medical And Surgical | Yes (X) | GeneralMedicalAndSurgicalInd |
| Teaching Hospital | Yes (X) | TeachingHospitalInd |
| Research Facility | Yes (X) | ResearchFacilityInd |
| Other | Urgent Care Center SEE PART V OF SCH H | OtherDesc |
Hospital Fclty Policies Prctc HospitalFcltyPoliciesPrctcGrp
Hospital Facility Name HospitalFacilityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MEMORIAL HOSP FOR CANCER & ALLIED DIS | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Facility | 1 | FacilityNum |
| First Licensed CY Or PY | false | FirstLicensedCYOrPYInd |
| Tax Exempt Hospital CY Or PY | false | TaxExemptHospitalCYOrPYInd |
| CHNA Conducted | Yes (true) | CHNAConductedInd |
| Community Definition | Yes (X) | CommunityDefinitionInd |
| Community Demographics | Yes (X) | CommunityDemographicsInd |
| Existing Resources | Yes (X) | ExistingResourcesInd |
| How Data Obtained | Yes (X) | HowDataObtainedInd |
| Community Health Needs | Yes (X) | CommunityHealthNeedsInd |
| Other Health Issues | Yes (X) | OtherHealthIssuesInd |
| Community Hlth Needs Id Process | Yes (X) | CommunityHlthNeedsIdProcessInd |
| Consulting Process | Yes (X) | ConsultingProcessInd |
| Prior CHNA Impact | Yes (X) | PriorCHNAImpactInd |
| CHNA Conducted | 22 | CHNAConductedYr |
| Take Into Account Others Input | Yes (true) | TakeIntoAccountOthersInputInd |
| CHNA Conducted With Other Fclts | Yes (true) | CHNAConductedWithOtherFcltsInd |
| CHNA Conducted With Non Fclts | false | CHNAConductedWithNonFcltsInd |
| CHNA Report Widely Available | Yes (true) | CHNAReportWidelyAvailableInd |
| Rpt Available On Own Website | Yes (X) | RptAvailableOnOwnWebsiteInd |
| Own Website URL | www.mskcc.org/communityserviceplans | OwnWebsiteURLTxt |
| Rpt Available Thru Other Method | Yes (X) | RptAvailableThruOtherMethodInd |
| Implementation Strategy Adopt | Yes (true) | ImplementationStrategyAdoptInd |
| Implementation Strategy Adpt | 22 | ImplementationStrategyAdptYr |
| Strategy Posted Website | Yes (true) | StrategyPostedWebsiteInd |
| Strategy Website URL | www.mskcc.org/communityserviceplans | StrategyWebsiteURLTxt |
| Organization Incur Excise Tax | false | OrganizationIncurExciseTaxInd |
| Elig Criteria Explained | Yes (true) | EligCriteriaExplainedInd |
| FPG Family Incm Lmt Free Dscnt | Yes (X) | FPGFamilyIncmLmtFreeDscntInd |
| FPG Family Incm Lmt Free Care | 500. | FPGFamilyIncmLmtFreeCarePct |
| FPG Family Incm Lmt Dscnt Care | 500. | FPGFamilyIncmLmtDscntCarePct |
| Income Level Criteria | Yes (X) | IncomeLevelCriteriaInd |
| Asset Level Criteria | Yes (X) | AssetLevelCriteriaInd |
| Medical Indigency Criteria | Yes (X) | MedicalIndigencyCriteriaInd |
| Insurance Status Criteria | Yes (X) | InsuranceStatusCriteriaInd |
| Underinsurance Stat Criteria | Yes (X) | UnderinsuranceStatCriteriaInd |
| Residency Criteria | Yes (X) | ResidencyCriteriaInd |
| Explained Basis | Yes (true) | ExplainedBasisInd |
| App Financial Asst Expln | Yes (true) | AppFinancialAsstExplnInd |
| Described Info | Yes (X) | DescribedInfoInd |
| Described Suprt Doc | Yes (X) | DescribedSuprtDocInd |
| Provided Hospital Contact | Yes (X) | ProvidedHospitalContactInd |
| Other Method | Yes (X) | OtherMethodInd |
| Includes Publicity Measures | Yes (true) | IncludesPublicityMeasuresInd |
| FAP Available On Website | Yes (X) | FAPAvailableOnWebsiteInd |
| FAP Available On Website URL | SEE SCH H, PART V, SECTION C | FAPAvailableOnWebsiteURLTxt |
| FAP App Available On Website | Yes (X) | FAPAppAvailableOnWebsiteInd |
| FAP App Available On Website URL | www.mskcc.org/financial-assistance | FAPAppAvailableOnWebsiteURLTxt |
| FAP Summary On Website | Yes (X) | FAPSummaryOnWebsiteInd |
| FAP Summary On Website URL | SEE SCH H, PART V, SECTION C | FAPSummaryOnWebsiteURLTxt |
| FAP Avlbl On Request No Charge | Yes (X) | FAPAvlblOnRequestNoChargeInd |
| FAP App Avlbl On Request No Chrg | Yes (X) | FAPAppAvlblOnRequestNoChrgInd |
| FAP Sum Avlbl On Request No Chrg | Yes (X) | FAPSumAvlblOnRequestNoChrgInd |
| Notified FAP Copy Bill Display | Yes (X) | NotifiedFAPCopyBillDisplayInd |
| Communtity Notified FAP | Yes (X) | CommuntityNotifiedFAPInd |
| FAP Translated | Yes (X) | FAPTranslatedInd |
| Other Publicity | Yes (X) | OtherPublicityInd |
| FAP Actions On Nonpayment | Yes (true) | FAPActionsOnNonpaymentInd |
| Permit No Actions | Yes (X) | PermitNoActionsInd |
| Collection Activities | false | CollectionActivitiesInd |
| Provided Written Notice | Yes (X) | ProvidedWrittenNoticeInd |
| Made Effort Orally Notify | Yes (X) | MadeEffortOrallyNotifyInd |
| Processed FAP Application | Yes (X) | ProcessedFAPApplicationInd |
| Other Actions Taken | Yes (X) | OtherActionsTakenInd |
| Nondis Emergency Care Policy | Yes (true) | NondisEmergencyCarePolicyInd |
| Look Back Medicare Private | Yes (X) | LookBackMedicarePrivateInd |
| Amounts Generally Billed | false | AmountsGenerallyBilledInd |
| Gross Charges | false | GrossChargesInd |
Supplemental Information SupplementalInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART V FACILITY INFORMATION | FormAndLineReferenceDesc |
| Explanation | LINE 3E WE PRIORITIZED THE IDENTIFIED CANCER-RELATED COMMUNITY HEALTH NEEDS BASED ON CERTAIN CRITERION AS OUTLINED IN MSK'S 2022-2024 CHNA AND LINKED THEM TO APPROPRIATE PROGRAMS AND ACTIVITIES AS DESCRIBED IN THE IMPLEMENTATION STRATEGIES POSTED TO OUR WEBSITE AT WWW.MSKCC.ORG/COMMUNITYSERVICEPLANS. LINE 5 TO UPDATE OUR UNDERSTANDING OF CURRENT CANCER-RELATED NEEDS WITHIN OUR CATCHMENT AREA, IN 2022 MSK INVITED COMMUNITY STAKEHOLDERS TO PARTICIPATE IN MSK'S COMMUNITY HEALTH NEEDS ASSESSMENT LEADERSHIP FORUM. INVITATIONS TO PARTNER IN OUR CHNA LEADERSHIP FORUM WERE SENT TO 225 COMMUNITY REPRESENTATIVES FROM WHICH 60 ORGANIZATIONS SERVING UNDERSERVED POPULATIONS PARTICIPATED. THESE ORGANIZATIONS ALSO HELPED DISSEMINATE THE GREATER NEW YORK HOSPITAL ASSOCIATION CHNA SURVEY TO THEIR AUDIENCES. PARTICIPANTS INCLUDED REPRESENTATIVES FROM COMMUNITY-BASED ORGANIZATIONS AND LOCAL HEALTH AGENCIES, LOCAL GOVERNMENT OFFICIALS, HEALTHCARE PROVIDERS, BUSINESSES, HEALTHCARE ADVOCATES, AND LABOR UNIONS. MSK'S VIRTUAL CHNA LEADERSHIP FORUM WAS HELD IN MAY 2022. PARTICIPANTS WERE ASSIGNED TO GROUPS RANGING IN SIZE BETWEEN 6-12 PEOPLE AND WERE ASKED TO SPEAK ON BEHALF OF THE DIVERSE LOCALIZED POPULATIONS THEIR ORGANIZATIONS AND AGENCIES SERVE INCLUDING HARLEM, QUEENS, BROOKLYN, NEW JERSEY, LONG ISLAND, AND WESTCHESTER. MSK'S CHNA COMMITTEE DEVELOPED A DISCUSSION GUIDE, WHICH SUPPORTED DEFINING CANCER-RELATED HEALTH PRIORITIES AND CONCERNS FACING AREA RESIDENTS (ESPECIALLY FOR DIVERSE AND MEDICALLY UNDERSERVED POPULATIONS) AND EXPLORING OPPORTUNITIES FOR MSK TO PARTNER WITH COMMUNITY-BASED ORGANIZATIONS TO ADDRESS HEALTH DISPARITIES. LEADING HEALTH NEEDS WERE IDENTIFIED BY GROUP CONSENSUS AND CATEGORIZED INTO FIVE BROAD AREAS FOR IMPROVING CANCER OUTCOMES: SOCIAL DETERMINANTS OF HEALTH, ACCESS TO CLINICAL SERVICES, LANGUAGE AND CULTURAL SENSITIVITY, SOCIAL SUPPORT AND COMMUNITY PARTNERSHIPS. AFTER THE FORUM, THE FINDINGS WERE SHARED WITH OUR CHNA PARTNERS FOR CONFIRMATION AND ADDITIONAL FEEDBACK. COMMUNITY ORGANIZATIONS THAT PROVIDED INPUT FOR MSK'S CHNA INCLUDE: A BETTER COLLEGE POINT CIVIC ASSOCIATION ADELPHI NY STATEWIDE BREAST CANCER HOTLINE AMERICAN CANCER SOCIETY ARAB AMERICAN ASSOCIATION OF NY ARAB AMERICAN FAMILY SUPPORT CENTER BREAST CANCER ALLIANCE BRONX HEALTH & HOUSING CONSORTIUM BRONX HEALTH REACH BROOKLYN COLLEGE CANCER CENTER BROTHER TO BROTHER CALLEN LORDE CANCER AND CAREERS CANCER CARE CANCER SUPPORT TEAM COALICIN MEXICANA COUNCILWOMAN MERCEDES NARCISSE OFFICE, 46TH DISTRICT CSP OF NASSAU COUNTY DILIGENTLY SERVING IMMIGRANTS INC. GILDA'S - RED DOOR COMMUNITY GILDA'S CLUB OF WESTCHESTER HEADSTRONG FOUNDATION HOPE COMMUNITIES INC. LATINA SHARE LATINO COMMISSION ON AIDS - NYC REGION LEUKEMIA & LYMPHOMA SOCIETY LONG ISLAND NETS MAKE THE ROAD NY MEXICAN CONSULATE / VENTANILLA DE SALUD MIDDLESEX COUNTY OFFICE OF HEALTH SERVICES MOLLOY COLLEGE MONMOUTH COUNTY REGIONAL HEALTH COMMISSION NO. 1 NASSAU COUNTY DEPARTMENT OF HEALTH NASSAU LIBRARY SYSTEM NATIONAL ASSOCIATION OF NIGERIAN NURSES IN NORTH AMERICA NJCEED NOSTRAND GARDENS CIVIC ASSOCIATION NEW YORK CITY DISTRICT COUNCIL OF CARPENTERS OCEAN MONMOUTH HEALTH ALLIANCE OPEN DOOR FAMILY MEDICAL CENTERS RISEBOROUGH COMMUNITY PARTNERSHIPS RYE YMCA SISTERS UNITED IN HEALTH SOMERSET MORRIS CHRONIC DISEASE COALITION SOUL RYEDERS SOUTH ASIAN COUNCIL FOR SOCIAL SERVICES SUNNYSIDE COMMUNITY SERVICES SUPPORT CONNECTION SUSAN G. KOMEN BREAST CANCER ORGANIZATION THE ABYSSINIAN BAPTIST CHURCH THE BUSINESS COUNCIL OF WESTCHESTER THE COLETTE COYNE MELANOMA AWARENESS CAMPAIGN THE ISAACS CENTER AND GODDARD RIVERSIDE COMMUNITY CENTER UNION COUNTY OFFICE OF HEALTH MANAGEMENT UNION FOUTA UNIONDALE LIBRARY VISITING NURSES SERVICE OF NEW YORK - VNSNY CHOICE VNACJ COMMUNITY HEALTH CENTER WESTCHESTER JEWISH COMMUNITY SERVICES WYCKOFF HEALTH MEDICAL CENTER POSITIVE HEALTH MANAGEMENT LINE 6A MSK PARTICIPATED IN THE GREATER NEW YORK HOSPITAL ASSOCIATION (GNYHA) CHNA SURVEY COLLABORATIVE, COMPRISING OF 14 HOSPITALS AND HEALTH SYSTEMS. THE COLLABORATIVE WAS CONVENED TO SUPPORT AND STREAMLINE HOSPITAL EFFORTS IN IDENTIFYING LEADING COMMUNITY HEALTH NEEDS AND HELPING MEET THE REQUIREMENTS OF THE FEDERAL CHNA AND THE NEW YORK STATE COMMUNITY SERVICE PLAN. MEMBER HOSPITALS AGREED TO DISSEMINATE A SURVEY THAT WAS THEN ANALYZED BY GNYHA. THE FOLLOWING HOSPITALS AND HEALTH SYSTEMS PARTICIPATED IN THE GNYHA CHNA SURVEY COLLABORATIVE: MAIMONIDES MEDICAL CENTER AND NEW YORK COMMUNITY HOSPITAL MEDISYS HEALTH NETWORK MEMORIAL SLOAN KETTERING CANCER CENTER MONTEFIORE HEALTH SYSTEM NEWYORK-PRESBYTERIAN HOSPITAL NIAGARA FALLS MEMORIAL MEDICAL CENTER NORTHWELL HEALTH NUVANCE HEALTH ONE BROOKLYN HEALTH SYSTEM SBH HEALTH SYSTEM/ST. BARNABAS HOSPITAL ST. JOHN'S RIVERSIDE HOSPITAL THE ROCKEFELLER UNIVERSITY WMC HEALTH NETWORK LINE 7D SUMMARY FINDINGS OF MSK'S COMMUNITY HEALTH NEEDS ASSESSMENT (CHNA) WERE SENT TO COMMUNITY-BASED ORGANIZATIONS WITH WHOM WE WORKED AND INVITED THEIR FEEDBACK. WE ALSO INCORPORATED THE CHNA INTO OUR 2022-2024 NEW YORK STATE COMMUNITY SERVICE PLAN (CSP) TO ADDRESS THE IDENTIFIED HEALTH NEEDS. THE FINAL REPORT IS BEING SHARED VIA EMAIL WITH AREA OFFICIALS AND HEALTH AGENCIES, CIVIC LEADERS, AND COMMUNITY ORGANIZATIONS. IT IS ALSO PUBLISHED ON MSK'S WEBSITE FOR PUBLIC INFORMATION AND INPUT AT MSKCC.ORG/COMMUNITYSERVICEPLANS. MSK IS PLANNING A FOLLOW UP FORUM WITH CHNA PARTICIPANTS IN 2023 TO SHARE OUR IMPLEMENTATION PLAN AND INVITE FEEDBACK. MSK WILL MAKE ANNUAL UPDATES TO ITS COMMUNITY SERVICE PLAN WHENEVER REQUIRED BY THE NEW YORK DEPARTMENT OF HEALTH. LINE 11 MSK HAS A LONG-STANDING COMMITMENT TO ADDRESS MANY OF THE CANCER-RELATED NEEDS IDENTIFIED THROUGH ITS RECENT CHNA. THE CHNA SURVEY DEVELOPED BY GNYHA AND DISSEMINATED TO COMMUNITY MEMBERS BY 14 HOSPITALS AND HEALTH SYSTEMS, INCLUDING MSK, CONFIRMED CANCER IS A LEADING CAUSE OF DEATH AND AN IMPORTANT CONCERN OF THE COMMUNITY. MSK'S COMMUNITY BENEFIT PROGRAMS WILL CONTINUE TO INCLUDE AN ARRAY OF CANCER-FOCUSED ACTIVITIES AROUND RESEARCH, EDUCATION, PATIENT FINANCIAL ASSISTANCE, AND PATIENT SCREENING AND CARE. IN ADDITION, MSK WILL CONTINUE TO SUPPORT THE TOBACCO PREVENTION AND CHRONIC DISEASE PREVENTIVE CARE AND MANAGEMENT FOCUS AREAS OF THE NEW YORK STATE PREVENTION AGENDA. MSK IS CURRENTLY ADDRESSING MANY OTHER CANCER-FOCUSED TOPICS IDENTIFIED THROUGH THE CHNA, INCLUDING ACCESS TO CLINICAL SERVICES, SOCIAL DETERMINANTS OF HEALTH, AND LANGUAGE AND CULTURAL SENSITIVITY. FOR EXAMPLE, MSK'S RALPH LAUREN CENTER PROVIDES FREE AND DISCOUNTED CANCER CARE, PREVENTION, AND SCREENING, AS WELL AS HEALTH-RELATED AND NUTRITIONAL EDUCATION AT NO COST TO THE COMMUNITY. IN 2023, MEMORIAL MEDICAL CARE, PC, A PRACTICE OF MSK PHYSICIANS, OPENED IN THE FLATBUSH NEIGHBORHOOD OF BROOKLYN. THIS NEW FACILITY PROVIDES GREATER ACCESS TO CARE FOR THE FLATBUSH COMMUNITY, WHERE 22 PERCENT OF RESIDENTS LIVE IN POVERTY, AND CANCER IS THE LEADING CAUSE OF PREMATURE DEATH. THE SITE CONNECTS PATIENTS TO ADVANCED IMAGING, STATE-OF-THE-ART THERAPIES, AND CUTTING-EDGE CLINICAL TRIALS AT MSK'S OTHER FACILITIES. PROGRAMS THROUGH MSK'S IMMIGRANT HEALTH AND CANCER DISPARITIES SERVICE (IHCD) ADDRESS PREVENTION/SCREENING, NUTRITION EDUCATION, AND HEALTHCARE REFERRALS FOR IMMIGRANTS. THESE PROGRAMS INCLUDE THE ARAB HEALTH INITIATIVE, VENTANILLA DE SALUD (HEALTH WINDOW WITH MEXICAN CONSULATE), MOBILE HEALTH UNIT, AND THE TAXI NETWORK, AMONG OTHERS. IHCD ALSO RUNS THE FOOD TO OVERCOME DISPARITIES PROGRAM (F.O.O.D.), WHICH TACKLES FOOD INSECURITY AMONG UNDERSERVED CANCER PATIENTS BY PROVIDING NUTRITION EDUCATION AND FREE NUTRITIOUS FOODS THROUGH FOOD PANTRIES AT 15 CANCER TREATMENT SITES ACROSS NEW YORK CITY AND LONG ISLAND. F.O.O.D. PARTNERS WITH COMMUNITY-BASED ORGANIZATIONS, HOSPITALS AND OTHER AGENCIES TO CONDUCT RESEARCH ON THE IMPACT OF THE PROGRAM TO DECREASE FOOD INSECURITY AND INCREASE CANCER TREATMENT ADHERENCE AND PATIENT OUTCOMES. MSK'S TOBACCO TREATMENT PROGRAM (TTP) WORKS TO REDUCE TOBACCO-RELATED CANCER BURDENS AND ADDRESSES DISPARITIES THROUGH EVIDENCE-BASED CLINICAL CARE, EDUCATION, TRAINING, COMMUNITY OUTREACH, AND RIGOROUS RESEARCH. TO ADDRESS LANGUAGE ASSISTANCE FOR LIMITED ENGLISH PROFICIENCY PATIENTS, MSK ENSURES ALL PATIENTS AND FAMILIES ARE ABLE TO CONNECT TO HIGH-QUALITY CANCER CARE THROUGH MEDICAL INTERPRETING AND TRANSLATION SERVICES. MSK ALSO PRODUCES ONLINE AND PRINT RESOURCES IN MULTIPLE LANGUAGES, INCLUDING ALBANIAN, ARABIC, BENGALI, CHINESE, FRENCH, GERMAN, GREEK, GUJARATI, HEBREW, HINDI, ITALIAN, JAPANESE, KOREAN, POLISH, PORTUGUESE, PUNJABI, RUSSIAN, SPANISH, UKRAINIAN, URDU, VIETNAMESE, AND YIDDISH. ALL MATERIALS PRODUCED ARE AVAILABLE TO THE PUBLIC IN A VIRTUAL PATIENT EDUCATION LIBRARY AT MSKCC.ORG/PE. THE LIBRARY HOSTS OVER 5,000 EDUCATIONAL RESOURCES AND HAD OVER 88 MILLION VIEWS SINCE 2020. IN ADDITION, FOR MORE THAN 20 YEARS, MSK'S MEDICAL INTERPRETING TRAINING AND EDUCATION PROGRAM HAS ADDRESSED THE LANGUAGE BARRIERS IN HEALTHCARE BY TRAINING BILINGUAL INDIVI | ExplanationTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Facility | 5 | FacilityNum |
Oth Hlth Care Fclts Not Hospital OthHlthCareFcltsNotHospitalGrp
Oth Hlth Care Fclts OthHlthCareFcltsGrp (5 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | FacilityFacilityTxt |
|---|---|---|---|---|
| MSK MONMOUTH | ||||
| 480 RED HILL ROAD | MIDDLE TOWN | NJ | 07748 | EXTENSION CLINIC |
| MSK BERGEN | ||||
| 225 SUMMIT AVENUE | MONTVALE | NJ | 07901 | EXTENSION CLINIC |
| MSK BASKING RIDGE | ||||
| 136 MOUNTAIN VIEW BLVD | BASKING RIDGE | NJ | 07920 | EXTENSION CLINIC |
| MSK CLINICAL GENETICS SERVICES | ||||
| 222 EAST 70TH STREET | NEW YORK | NY | 10021 | EXTENSION CLINIC |
| BENDHEIM CENTER FOR INTEGRATED MEDICINE | ||||
| 205 E64TH STREET | NEW YORK | NY | 10065 | EXTENSION CLINIC |
Supplemental Information Detail SupplementalInformationDetail (5 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE H, PART VI | PART 1, LINE 3A A PATIENT WITH INCOME LESS THAN OR EQUAL TO 500% OF THE FEDERAL POVERTY GUIDELINES IS ELIGIBLE FOR THE INSTITUTION'S FINANCIAL ASSISTANCE PROGRAM (FAP). THE INSTITUTION MAY REDUCE THE FEES INCURRED BY THE PATIENT OR ACCEPT AS FULL PAYMENT AMOUNTS PAID BY THE INSURANCE CARRIER ON THE PATIENT'S BEHALF. IN ADDITION, A PATIENT MAY ALSO QUALIFY FOR ASSISTANCE EVEN IF HIS/HER INCOME IS GREATER THAN THE THRESHOLD LIMIT. THE INSTITUTION ADJUSTS PATIENTS' INCOME FOR ROUTINE MONTHLY EXPENSES, INCLUDING TAXES, TO DETERMINE "DISPOSABLE INCOME". MSK ALSO DEDUCTS A SPECIFIC AMOUNT (DEBT BURDEN) AS A MONTHLY CLOTHES AND FOOD ALLOWANCE BASED ON A PATIENT'S FAMILY SIZE IN EVALUATING THE TYPE AND AMOUNT OF ASSISTANCE NEEDED. THE TABLE BELOW ILLUSTRATES THE INCOME GUIDELINE USED IN EVALUATING THE PATIENT'S FINANCIAL STATUS. FAMILY SIZE ALLOWED INCOME RESOURCE LEVELS 1 $ 67,950 $ 42,000 2 $ 91,550 $ 61,500 3 $115,150 $ 62,535 4 $138,750 $ 70,688 5 $162,350 $ 78,848 6 $185,950 $ 87,000 PART 1, LINE 3C THE MAXIMUM AMOUNT CHARGED TO PATIENTS DEEMED ELIGIBLE UNDER THE FAP FOR "EMERGENCY OR OTHER MEDICALLY NECESSARY CARE" IS THE AMOUNT THE INSTITUTION INITIALLY CONCLUDED A PATIENT CAN AFFORD TO PAY WHEN FINALIZING THE FAP APPLICATION. THIS AMOUNT IS DERIVED BY CALCULATING A PATIENT'S HOUSEHOLD "NET MONTHLY INCOMEDEDUCTING THE TOTAL AMOUNT OF ROUTINE MONTHLY BILLS. THE AMOUNT REMAINING IS WHAT WE CONSIDER THE PATIENT CAN PAY EACH MONTH. IF THE PATIENT'S HOUSEHOLD MONTHLY ROUTINE BILLS ARE MORE THAN OR EQUAL TO "NET MONTHLY INCOME", THE INSTITUTION ACCEPTS WHATEVER THE PATIENT'S INSURANCE PAYS AS PAYMENT IN FULL, (THE PATIENT WOULD NOT HAVE TO PAY ANYTHING OUT-OF-POCKET); UNLESS THE PATIENT HAS ASSETS SUCH AS A SECOND HOME, STOCKS, CERTIFICATE OF DEPOSITS, LARGE SAVINGS OR ANY OTHER ASSETS EXCLUDING RETIREMENT AND EDUCATION ACCOUNTS. PATIENTS WITH LARGE AMOUNTS OF ASSETS WHOSE ROUTINE MONTHLY BILLS ARE GREATER THAN THEIR "NET MONTHLY INCOME" MAY BE ELIGIBLE FOR REDUCED TIME AND PAYMENT ARRANGEMENT AND WOULD MAKE MONTHLY PAYMENTS (12 TO 18 MONTHS) TO PAY OFF THE AMOUNT THE INSTITUTION DETERMINED THEY CAN AFFORD TO PAY. ONCE THE FAP APPLICATION IS FINALIZED AND A PATIENT IS DEEMED ELIGIBLE TO PAY NOTHING OR A REDUCED TIME PAYMENT, THIS AGREEMENT IS EFFECTIVE FOR ONE YEAR AND INCLUDES THE PATIENT'S OUTSTANDING BALANCES. ALL PATIENTS ARE ADVISED OF MSK'S FAP, BUT AGAIN THE DETERMINATION IS ONLY DOCUMENTED IF THE PATIENT APPLIES FOR THE ASSISTANCE. |
| PART I, LINE 7G | MEMORIAL SLOAN KETTERING HAS CONSISTENTLY SET THE STANDARD OF CARE FOR PEOPLE WITH CANCER BY EMPHASIZING EARLY DETECTION, PRECISE DIAGNOSIS, AND INDIVIDUALLY TAILORED TREATMENT. THE HOSPITAL SUBSIDIZES CANCER SCREENING, TREATMENT, AND SUPPORT SERVICES TO FULFILL ITS MISSION AND TO HELP REDUCE CANCER HEALTH DISPARITIES AMONG MINORITY AND MEDICALLY UNDERSERVED POPULATIONS. THE RALPH LAUREN CENTER AT MEMORIAL SLOAN KETTERING CANCER CENTER WAS ESTABLISHED IN 2003 WITH GENEROUS FUNDING FROM THE RALPH LAUREN CORPORATE FOUNDATION AND THE LAUREN FAMILY TO ADDRESS SIGNIFICANT HEALTH DISPARITIES FOUND IN LOW-INCOME AND HISTORICALLY UNDERSERVED COMMUNITIES IN NEW YORK CITY. LOCATED IN HARLEM AND ASSISTING PEOPLE FROM ALL FIVE BOROUGHS, THE RALPH LAUREN CENTER (RLC) IS A MODEL FOR BROADENING ACCESS TO HIGH-STANDARD CANCER PREVENTION, DIAGNOSTICS, AND TREATMENT SERVICES. IN 2019, THE RLC WAS INCORPORATED WITHIN MSK, CREATING IMPORTANT OPPORTUNITIES TO EXPAND AND INCREASE SUSTAINABLE BENEFITS TO UNDERSERVED NEW YORKERS AFFECTED BY CANCER. MSK ALSO MERGED ITS BREAST EXAMINATION CENTER OF HARLEM INTO THE RLC THAT YEAR, STREAMLINING EFFORTS IN ONE CONVENIENT LOCATION. MSK RALPH LAUREN CENTER PROVIDES CANCER PREVENTION, SCREENING, DIAGNOSIS, TREATMENT, AND SOCIAL SERVICES, AS WELL AS FINANCIAL COUNSELING AND A FOOD PANTRY SUPPLEMENTED WITH NUTRITIONAL COUNSELING. RLC'S SCOPE OF SERVICES INCLUDE BREAST CANCER EVALUATION, DIAGNOSTIC AND TREATMENT SERVICES, INCLUDING CHEMOTHERAPY, FOR MOST CANCERS AND BLOOD DISEASES, AND SCREENING SERVICES FOR BREAST, CERVICAL, COLON, PROSTATE AND LUNG CANCER AND SMOKING CESSATION PROGRAM. RLC IS STAFFED BY MEDICAL ONCOLOGISTS, A BREAST SURGEON, APP'S, REGISTERED NURSES, PATIENT CARE TECHNICIANS, A DIETICIAN/NUTRITIONIST, RADIOLOGY TECHNOLOGISTS, AND LAB TECHNICIANS. REFERRALS TO CLINICIANS, PROGRAMS, AND FACILITIES WITHIN MEMORIAL HOSPITAL ARE COORDINATED FOR PATIENTS REQUIRING SUCH SERVICES. TO-DATE RLC HAS MANAGED MORE THAN 186,826 PATIENT VISITS SINCE ITS FOUNDING. APPROXIMATELY 22,326 VISITS WERE MADE BETWEEN APRIL 1, 2019 AND DECEMBER 31, 2022 WHEN RLC TRANSITIONED TO MSK. MORE THAN 2,324 FINANCIAL ASSESSMENTS WERE ALSO RECORDED, DURING THE PERIOD APRIL 1, 2019 AND DECEMBER 31, 2022. MEMORIAL SLOAN KETTERING'S PSYCHIATRY & BEHAVIORAL SERVICES DEPARTMENT IS COMMITTED TO THE URGENT AS WELL AS ROUTINE CARE OF PATIENTS WITH CANCER. OUR PSYCHIATRISTS AND PSYCHOLOGISTS HAVE EXPERTISE IN ASSISTING PATIENTS WITH THE SPECTRUM OF PSYCHIATRIC AND BEHAVIORAL ISSUES THAT CAN ARISE DURING DIAGNOSIS AND TREATMENT. THE DEPARTMENT ALSO WORKS TO DEEPEN ITS UNDERSTANDING AND EXPAND TREATMENT OPTIONS FOR ONCOLOGY PATIENTS AROUND THE GLOBE THROUGH CLINICAL TRIALS, RESEARCH, AND OTHER MEANS. TO ACCOMPLISH THESE GOALS, THE DIVISION OFFERS INPATIENT AND OUTPATIENT PSYCHOLOGICAL AND SOCIAL SUPPORT SERVICES TO PATIENTS, THEIR FAMILIES, AND CAREGIVERS. FUNDING FOR THE MEDICAID OUTPATIENT VISITS AND INPATIENT ENCOUNTERS ARE SUBSIDIZED BY MSK, AS ARE UNREIMBURSED TIME AND EFFORT BY NURSES TO STAFF A SMOKING CESSATION CLINIC. PHILANTHROPIC FUNDS ARE USED TO SUPPORT A SIGNIFICANT NUMBER OF THE DEPARTMENT'S OVERALL CLINICAL AND TRAINING ACTIVITIES. SERVICES PROVIDED INCLUDE CONSULTATIONS AND EVALUATION, PSYCHOTHERAPY, MEDICATION MANAGEMENT AND PHARMACOTHERAPY, SUPPORTIVE COUNSELING, SMOKING CESSATION, HYPNOTHERAPY, VARIOUS DIAGNOSTIC TESTS, AND OTHERS. DURING 2022, THE DEPARTMENT EXPERIENCED 27,216 INPATIENT AND OUTPATIENT ENCOUNTERS WITH 1,996 PATIENTS TREATED THROUGH THE SMOKING CESSATION PROGRAM. APPROXIMATELY $5.00M WAS EXPENDED BY THE DEPARTMENT TO SUPPORT ITS COMMUNITY BENEFIT-RELATED PROGRAMS, OF WHICH $1.80M, OR 36%, WERE INCURRED FOR SUBSIDIZED CLINICAL CARE. AT MSK WE BELIEVE IN CARING FOR THE WHOLE PERSON, NOT JUST THE DISEASE OR SYMPTOM. INTEGRATIVE MEDICINE WEAVES NATURAL TREATMENTS SUCH AS ACUPUNCTURE, MASSAGE, AND YOGA INTO OUR OVERALL CARE PLAN. ALL OF OUR HOLISTIC HEALTH SERVICES AND PROGRAMS ARE BASED ON THE LATEST SCIENTIFIC EVIDENCE. THE INTEGRATIVE MEDICINE SERVICE PROVIDES FREE CLINICAL CARE FOR INPATIENTS. DURING 2022, WE SERVICED 6,656 INPATIENT VISITS. THESE CLINICAL SERVICES INCLUDED MUSIC THERAPY, TOUCH THERAPY, ACUPUNCTURE, YOGA AND YOGIC BREATHING, MEDITATION AND GUIDED IMAGERY, KARATE AND DANCE THERAPY. WE ALSO PROVIDED EXTENSIVE EDUCATION FOR PATIENTS AND CAREGIVERS DURING BEDSIDE AND GROUP VISITS. THESE SERVICES ARE ALSO AVAILABLE FREE OF CHARGE TO PATIENTS SEEN ON THE OUTPATIENT PEDIATRIC FLOOR. DURING 2022, 995 OUTPATIENT PEDIATRIC VISITS WERE COMPLETED. IN ADDITION, WE OFFER OUTPATIENT ACUPUNCTURE CONSULTATIONS TO ANYONE IN THE COMMUNITY AT NO COST TO THEM. THESE CONSULTATIONS ADVISED CLIENTS ON HOW ACUPUNCTURE BENEFIT THEIR CONDITION BASED ON THEIR SPECIFIC THERAPEUTIC NEEDS. THERE WERE 87 ACUPUNCTURE CONSULTATIONS PROVIDED IN 2022. THE DEPARTMENT INCURRED $1.11M IN PERSONNEL COST TO DELIVER COMMUNITY BENEFIT-RELATED PROGRAMS. $.35M OR 30% WERE SPENT ON SUBSIDIZED CLINICAL CARE. |
| PART I, LINE 7, COL (F) | THE BAD DEBT EXPENSE WAS NOT INCLUDED ON LINE 25 IN ACCORDANCE WITH GENERALLY ACCEPTED ACCOUNTING PRINCIPLES (GAAP). PART I, LINE 7 FINANCIAL ASSISTANCE REPRESENTS THE COST OF SERVICES PROVIDED TO PATIENTS WHO CANNOT AFFORD HEALTH CARE SERVICES DUE TO INADEQUATE RESOURCES AND/OR ARE UNINSURED OR UNDERINSURED. A PATIENT IS CLASSIFIED AS A FINANCIAL ASSISTANCE PATIENT IN ACCORDANCE WITH THE INSTITUTION'S ESTABLISHED POLICIES AND WHERE INSUFFICIENT PAYMENT FOR SUCH SERVICES IS ANTICIPATED. THE INSTITUTION CONSIDERS PATIENTS FOR FINANCIAL ASSISTANCE IF HOUSEHOLD INCOME IS LESS THAN 500% OF THE FEDERAL POVERTY GUIDELINES, AND AS DESCRIBED IN OTHER SECTIONS OF THIS DOCUMENT. SERVICES PROVIDED AS FINANCIAL ASSISTANCE ARE NOT REPORTED AS REVENUE. THE COSTS REPORTED IN THE TABLE ON LINE 7, WERE BASED ON VARIOUS SOURCES. FINANCIAL ASSISTANCE AND THE UNREIMBURSED MEDICAID COST WERE BASED ON A COST-TO-CHARGE RATIO CALCULATION. THE TOTAL CHARGES ASSOCIATED WITH THESE PROGRAMS ARE MULTIPLIED BY A RATIO OF HISTORICAL EXPENSES TO CHARGES AS DERIVED FROM THE HOSPITAL'S NEW YORK STATE INSTITUTIONAL COST REPORT. THE COSTS ASSOCIATED WITH A PORTION OF THE HEALTH PROFESSIONAL EDUCATION COMMUNITY BENEFIT ARE OBTAINED FROM THE STEP-DOWN OF COSTS PREPARED AS PART OF THE NEW YORK STATE INSTITUTIONAL COST REPORT. TO ARRIVE AT THE AMOUNTS REPORTED IN THE TABLE ON LINE 7, ADDITIONAL STEPS AS OUTLINED BELOW WERE TAKEN. UNPAID COST OF GOVERNMENT-SPONSORED HEALTH CARE REPRESENTS THE ESTIMATED DIFFERENCE BETWEEN THE PAYMENTS MADE UNDER THE MEDICARE AND MEDICAID PROGRAMS AND THE INSTITUTION'S COST OF PROVIDING THESE SERVICES AS CALCULATED ABOVE. THE INSTITUTION SUBTRACTS ALL REVENUES RECEIVED FROM THE MEDICARE AND MEDICAID PROGRAMS TO DETERMINE THE COMMUNITY BENEFIT PROVIDED. RESEARCH COMMUNITY BENEFIT COSTS REPRESENT ALL COSTS FOR BASIC TRANSLATIONAL AND CLINICAL RESEARCH, SUPPORTED BY INSTITUTIONAL FUNDS, GOVERNMENTAL, AND OTHER NON-PROFIT ORGANIZATIONS. THE INSTITUTION IS A PREEMINENT PROVIDER OF HEALTH TRAINING TO HEALTH PROFESSIONALS WHO DESIRE TRAINING IN THE SKILLS NECESSARY TO TREAT CANCER PATIENTS. THE INSTITUTION TRAINS PHYSICIANS, SCIENTISTS, MEDICAL STUDENTS, RADIOLOGY STUDENTS, NURSING STUDENTS, SOCIAL WORK STUDENTS AND INDIVIDUALS LOOKING TO CREATE A CAREER IN THE FIELD OF CANCER BIOLOGY. THE AMOUNTS REPORTED AS HEALTH TRAINING REPRESENT INSTITUTIONAL FUNDS, AS WELL AS COSTS IN EXCESS OF AMOUNTS REIMBURSED BY THIRD-PARTY PAYERS SUCH AS TRAINING GRANT REVENUES AND DIRECT MEDICAL EDUCATION PAYMENTS FROM THE MEDICARE PROGRAM. AS INDICATED EARLIER, MSK'S PSYCHIATRY & BEHAVIORAL SERVICES DEPARTMENT OFFERS INPATIENT AND OUTPATIENT PSYCHOLOGICAL SERVICES AND OTHER QUALIFYING SUBSIDIZED COMMUNITY BENEFIT PROGRAMS TO PATIENTS. SUBSIDIZED CANCER SCREENINGS ARE ALSO OFFERED THROUGH OTHER COMMUNITY PROGRAMS PROVIDED BY THE INSTITUTION. THE COST ASSOCIATED WITH THESE PATIENTS' CARE ARE REPORTED IN THE TABLE ON LINE 7, BASED ON PATIENT CARE COST TO CHARGE RATIO, WHERE APPLICABLE. ALL SALARY EXPENSES RELATED TO OTHER SUBSIDIZED PATIENT CARE BY ATTENDING PHYSICIANS, CLINICAL AND RESEARCH FELLOWS AND NURSE PRACTITIONERS ARE ALSO REPORTED IN THE TABLE ON LINE 7G. PART II MSK ENGAGES IN AND SUPPORTS COALITION-BUILDING ACTIVITIES THAT PROMOTE THE HEALTH OF THE COMMUNITIES THE INSTITUTION SERVES. STAFF MEMBERS ARE ENCOURAGED TO SHARE THEIR CLINICAL EXPERTISE AND EXPERIENCE WITH PARTNERING HEALTHCARE FACILITIES AND COMMUNITY ORGANIZATIONS. STAFF MEMBERS SERVE AND PARTICIPATE IN NUMEROUS COMMUNITY GROUPS INCLUDING THE AMERICAN CANCER SOCIETY, THE GREATER NEW YORK HOSPITAL ASSOCIATION, AND MANY HEALTH IMPROVEMENT ADVOCACY GROUPS FOR VARIOUS TYPES OF CANCER. ALTHOUGH THE SIGNIFICANT COST OF STAFF TIME DEVOTED TO THESE ACTIVITIES IS NOT QUANTIFIED BY THE CENTER, THE INSTITUTION CONSIDERS THESE EFFORTS TO COLLABORATE AND BUILD COMMUNITY RESOURCES TO BE OF SIZEABLE COMMUNITY BENEFIT. |
| PART III, LINE 2 | THE AMOUNT ON LINE 2 OF PART III IS THE ACTUAL 2022 BAD DEBT WRITE-OFF WHICH IS DERIVED BY TAKING THE GROSS CHARGES ASSOCIATED WITH THE PROVISIONS FOR BAD DEBTS AND MULTIPLYING BY A RATIO OF HISTORICAL EXPENSES TO CHARGES AS DERIVED FROM THE HOSPITAL'S NEW YORK STATE INSTITUTIONAL COST REPORT. A SEPARATE RATIO IS CALCULATED FOR EACH TYPE OF PATIENT CARE ACTIVITY: INPATIENT, OUTPATIENT, AND PHYSICIAN. PART III, LINE 3 PATIENTS CAN PURSUE FINANCIAL ASSISTANCE THROUGH MSK'S FINANCIAL ASSISTANCE PROGRAM. IF A PATIENT IS FOUND TO HAVE THE APPROPRIATE RESOURCES TO PAY FOR HEALTH SERVICES AND DOES NOT OR CHOOSES NOT TO PARTICIPATE IN AVAILABLE HEALTH BENEFIT PROGRAMS, THE INSTITUTION WILL BEGIN COLLECTION PROCEEDINGS IN ACCORDANCE WITH THE INSTITUTION'S POLICY. ONCE DEEMED UNCOLLECTABLE, THE CHARGES ARE CLASSIFIED AS BAD DEBTS AND ARE CHARGED OFF AS SUCH. THE AMOUNT ON LINE 3, OF PART III, REFLECTS THE COST OF THESE ACCOUNTS AS CALCULATED BASED ON THE COST-TO-CHARGE RATIO METHODOLOGY DESCRIBED EARLIER. IN DETERMINING THE AMOUNT THAT REASONABLY COULD BE ATTRIBUTABLE TO PATIENTS WHO LIKELY WOULD QUALIFY FOR FINANCIAL ASSISTANCE UNDER THE INSTITUTION'S POLICY, THE INSTITUTION REVIEWED THE CASES THAT WERE CLOSED WITH AN "INCOMPLETE" STATUS IN THE FINANCIAL ASSISTANCE PROGRAM DURING 2018 THROUGH 2022. THE INSTITUTION THEN COMPARED THESE CASES AGAINST THE BAD DEBT WRITE-OFFS FROM 2022. PART III, LINE 4 THE INSTITUTION FOLLOWS GENERALLY ACCEPTED ACCOUNTING PRINCIPLES IN REPORTING ON BAD DEBT EXPENSES. THEREFORE, A DETAILED DESCRIPTION OF THE BAD DEBT POLICY IS NOT REQUIRED IN THE FOOTNOTES TO THE AUDITED FINANCIAL STATEMENTS. PART III, LINE 8 THE MEDICARE LOSS REFLECTS LOSSES FROM BOTH HOSPITAL AND PHYSICIANS' ACTIVITY. PHYSICIAN REVENUE IS SHOWN AS OTHER REVENUE ON THE MEDICARE COST REPORT. COSTS DISALLOWED BY THE MEDICARE PROGRAM, BUT WHICH ARE INCURRED IN PROVIDING CARE TO MEDICARE BENEFICIARIES HAVE BEEN INCLUDED. PART III, LINE 9B THE INSTITUTION DOES NOT PURSUE COLLECTIONS FROM PATIENTS APPLYING FOR FINANCIAL ASSISTANCE. IF, HOWEVER, COLLECTIONS WERE INITIATED, THE EFFORT IS IMMEDIATELY SUSPENDED WHEN THE PATIENT APPLIES FOR FINANCIAL ASSISTANCE. IF THE PATIENT QUALIFIES FOR THE FAP WITH ZERO FEE PAYMENT, THE INSTITUTION ACCEPTS AS FULL SETTLEMENT ANY AMOUNT PAID BY THE INSURANCE CARRIER ON THE PATIENT'S BEHALF. ADDITIONALLY, IF A PATIENT QUALIFIES FOR A TIME PAYMENT PLAN (TPP), ALL OTHER CHARGES APART FROM THE AGREED TPP AMOUNT IS WRITTEN OFF AS FINANCIAL ASSISTANCE. FOR EXAMPLE, IF THE AGREEMENT CALLS FOR THE PATIENT TO MAKE AN ANNUAL PAYMENT OF $2,400 ($200 MONTHLY), THEN ALL OTHER CHARGES ACCRUING TO THE PATIENT ARE CANCELED AND WRITTEN OFF AS FINANCIAL ASSISTANCE. ANNUALLY, THE PATIENT'S CASE IS RE-EVALUATED AND ADJUSTMENTS MADE BASED ON CHANGING CIRCUMSTANCES. |
| PART VI, LINE 2 | THE CHNA IS THE MEANS BY WHICH THE INSTITUTION ASSESSES THE HEALTH NEEDS OF THE COMMUNITY. SEE PART V, SECTION B. PART VI, LINE 3 SINCE 1987, MSK HAS HAD A FINANCIAL ASSISTANCE PROGRAM IN PLACE TO ASSIST UNDERINSURED AND UNINSURED PATIENTS WHO ARE EXPERIENCING DIFFICULTIES MEETING THEIR FINANCIAL RESPONSIBILITIES TO MEMORIAL HOSPITAL AND ITS PHYSICIANS. FINANCIAL COUNSELORS WORK WITH PATIENTS AND INSURANCE COMPANIES INCLUDING MEDICARE AND MEDICAID TO HELP THE PATIENTS TO ACCESS SERVICES. THOSE WHO DO NOT QUALIFY FOR PUBLICLY AVAILABLE HEALTH INSURANCE, OR WHO ARE UNABLE TO PAY THEIR PORTION OF FEES ABOVE INSURANCE REIMBURSEMENT, MAY OBTAIN HELP THROUGH THE INSTITUTION'S FAP IF THEY ARE ELIGIBLE. THE PREMISE OF THE PROGRAM IS THAT ALL PATIENTS ARE EXPECTED TO CONTRIBUTE TO THEIR CARE BASED ON THEIR FINANCIAL ABILITY. THE FAP EMPLOYS SEVERAL STRATEGIES TO INCREASE PATIENTS' AWARENESS OF THE PROGRAM. DURING THE REGISTRATION PROCESS, FINANCIAL INTERVIEWERS EDUCATE PATIENTS ON THE VARIOUS PROGRAMS AVAILABLE TO THEM, INCLUDING GOVERNMENTAL PROGRAMS AND THE FINANCIAL ASSISTANCE PROGRAMS. MSK PERSONNEL SENDS THE FAP BROCHURE WITH THE INITIAL HOSPITAL BILL TO EVERY NEW PATIENT TO MAKE THEM AWARE OF THE CHARITY CARE/FINANCIAL ASSISTANCE PROGRAM. THE FAP IS ALSO MENTIONED IN EVERY STATEMENT AND LETTER THAT SENT TO A PATIENT. MOREOVER, THE FAP IS AGAIN MENTIONED IN EVERY COLLECTION LETTER SENT TO PATIENTS BY THE COLLECTION AGENCIES. EVEN AFTER A PATIENT'S ACCOUNT IS SENT TO COLLECTIONS, HE/SHE CAN STILL APPLY FOR FINANCIAL ASSISTANCE. IT IS NEVER TOO LATE TO APPLY FOR FINANCIAL ASSISTANCE AND RETROACTIVE FAP COVERAGE WOULD BE GIVEN IF A PATIENT IS DETERMINED ELIGIBLE FOR ASSISTANCE. INFORMATION ABOUT THE FINANCIAL ASSISTANCE PROGRAM IS ALSO AVAILABLE ON THE INSTITUTION'S WEBSITE AT WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE OR BY CALLING OUR DEDICATED FINANCIAL ASSISTANCE LINE AT (212) 639-3810. PART VI, LINE 4 MSK'S INPATIENT HOSPITAL IS IN MID-MANHATTAN WITH ADDITIONAL OUTPATIENT TREATMENT CENTERS IN BROOKLYN, LONG ISLAND, WESTCHESTER COUNTY, AND NEW JERSEY. OUR PRIMARY CATCHMENT AREA ENCOMPASSES 23 COUNTIES ACROSS THE FIVE BOROUGHS OF NEW YORK CITY, LONG ISLAND, SOUTHERN NEW YORK STATE, NEW JERSEY, AND SOUTHWESTERN CONNECTICUT. A TOTAL OF 214,342 PATIENTS WERE SEEN AT MSK'S FACILITIES IN 2022, INCLUDING 194,242 (90.6 PERCENT) PATIENTS FROM THE TRI-STATE AREA (NY, NJ, CT); 19,010 (8.9 PERCENT) PATIENTS FROM OTHER PARTS OF THE UNITED STATES; AND 1,090 (0.5 PERCENT) PATIENTS FROM OTHER COUNTRIES. THESE PATIENTS ACCOUNTED FOR 24,113 ADMISSIONS TO OUR HOSPITAL WITH 170,076 RELATED PATIENT DAYS AND 686,000 OUTPATIENT VISITS AT OUR COMBINED FACILITIES IN NEW YORK CITY AND THE REGION. PART VI, LINE 5 AT MSK, WE ARE UNITED BY A SINGULAR VISION - ENDING CANCER FOR LIFE. OUR SPECIALIZED CARE TEAMS PROVIDE PERSONALIZED, COMPASSIONATE, EXPERT CARE TO PATIENTS OF ALL AGES. INFORMED BY BASIC RESEARCH DONE AT OUR SLOAN KETTERING INSTITUTE, SCIENTISTS ACROSS MSK COLLABORATE TO CONDUCT INNOVATIVE TRANSLATIONAL AND CLINICAL RESEARCH THAT IS DRIVING A REVOLUTION IN OUR UNDERSTANDING OF CANCER AS A DISEASE AND IMPROVING THE ABILITY TO PREVENT, DIAGNOSE, AND TREAT IT. MSK IS DEDICATED TO TRAINING THE NEXT GENERATION OF SCIENTISTS AND CLINICIANS, WHO GO ON TO PURSUE OUR MISSION AT MSK AND AROUND THE GLOBE. ONE OF THE WORLD'S MOST RESPECTED COMPREHENSIVE CENTERS DEVOTED EXCLUSIVELY TO CANCER, WE HAVE BEEN RECOGNIZED AS ONE OF THE TOP TWO CANCER HOSPITALS IN THE COUNTRY BY U.S. NEWS & WORLD REPORT FOR MORE THAN 30 YEARS. WE ARE NOT JUST CAREGIVERS, BUT THE CAREGIVERS WHO MAKE THE DIFFERENCE IN THE DARKEST HOURS. WE PROVIDE MULTIDISCIPLINARY CARE, WHERE EXPERTS FROM MANY FIELDS OF MEDICINE COME TOGETHER TO DEVELOP THE BEST TREATMENTS FOR INDIVIDUAL PATIENTS AND FOR THE TREATMENT OF PATIENTS WITH ALL TYPES OF CANCER. THIS HAS ALLOWED US TO BE AT THE FOREFRONT OF DEVELOPING TREATMENTS THAT ARE MORE EFFECTIVE AT TREATING CANCER, WHILE AT THE SAME TIME SPARING MANY PATIENTS FROM THE MOST SERIOUS SIDE EFFECTS OF TREATMENT. HAVING THE SCIENTISTS WHO ASK AND ANSWER THE TOUGHEST QUESTIONS, OUR BASIC AND TRANSLATIONAL RESEARCHERS HAVE MADE MANY SIGNIFICANT CONTRIBUTIONS TO THE SCIENTIFIC COMMUNITY'S UNDERSTANDING OF CANCER BIOLOGY AND CANCER GENETICS AS WELL AS TO RELATED FIELDS OF CELL BIOLOGY, MOLECULAR BIOLOGY, STRUCTURAL BIOLOGY, DEVELOPMENTAL BIOLOGY, MOLECULAR PHARMACOLOGY AND CHEMISTRY, IMMUNOLOGY, COMPUTATIONAL BIOLOGY, AND DRUG DEVELOPMENT. GENES FIRST IDENTIFIED IN OUR LABORATORIES ARE NOW THE FOCUS OF INTENSE RESEARCH IN OTHER LABORATORIES AROUND THE WORLD. DRUGS, MONOCLONAL ANTIBODIES, AND OTHER AGENTS FIRST DEVELOPED IN OUR LABORATORIES HAVE GONE ON TO GAIN REGULATORY APPROVAL FOR TREATING PATIENTS WORLDWIDE. RECENT EXPANSION OF OUR LABORATORY SPACE HAS ALLOWED US TO GROW OUR RESEARCH EFFORTS SO THAT GOING FORWARD WE CAN CONTINUE TO MAKE DISCOVERIES THAT WILL CHANGE THE WAY THE WORLD UNDERSTANDS CANCER AND AID IN THE DEVELOPMENT OF BETTER TREATMENTS FOR CANCER PATIENTS EVERYWHERE. IN 2022, MSK SPENT $755.90M IN SUPPORT OF ITS RESEARCH MISSION, OF WHICH $241.20M WAS SPONSORED BY GOVERNMENTAL AND OTHER NON-PROFIT ORGANIZATIONS, $154.82M FROM PHILANTHROPY, AND $359.63M FROM THE INSTITUTION'S FUNDS. TRAINING THE NEXT GENERATION IS AN IMPORTANT EXAMPLE OF HOW THE INSTITUTION MAKES CONTRIBUTIONS TO THE CARE AND TREATMENT OF CANCER PATIENTS FAR BEYOND ITS OWN WALLS THROUGH WORKFORCE DEVELOPMENT. OUR TRAINING, GRADUATE, AND CONTINUING EDUCATION PROGRAMS PREPARE PHYSICIANS, SCIENTISTS, NURSES, AND TECHNICIANS TO BE LEADERS IN THEIR CHOSEN FIELDS. THESE HEALTHCARE PROVIDERS CAN THEN TAKE THE EXPERTISE GAINED FROM WORKING WITH OUR SPECIALISTS TO OTHER HEALTHCARE INSTITUTIONS AROUND THE COUNTRY AND THROUGHOUT THE WORLD. MSK ALSO TRAINS GRADUATE STUDENTS AND POSTDOCTORAL RESEARCHERS WORKING IN MANY AREAS OF BASIC SCIENCE AND TRANSLATIONAL RESEARCH. WHEN THESE YOUNG SCIENTISTS COMPLETE THEIR TRAINING, THEY BRING THE SKILLS OBTAINED IN OUR LABORATORIES INTO THE ACADEMIC COMMUNITY AT LARGE AS WELL AS THE PRIVATE SECTOR. MSK SPONSORS SEVERAL PROGRAMS THAT GIVE MEDICAL STUDENTS, UNDERGRADUATES, AND HIGH SCHOOL STUDENTS THE OPPORTUNITY TO WORK AT THE INSTITUTION DOING CLINICAL AND LABORATORY RESEARCH. THROUGH THESE PROGRAMS, MSK STRIVES TO INCREASE THE PIPELINE OF SCIENTISTS AND PHYSICIANS WORKING IN ONCOLOGY. IN 2020, THE ORGANIZATION ESTABLISHED THE OFFICE OF HEALTH EQUITY (OHE) TO ADDRESS CANCER DISPARITIES THAT EXIST DUE TO RACIAL, ETHNIC, CULTURAL, OR SOCIOECONOMIC BARRIERS. THROUGH A PATIENT CENTRIC FOCUS, THE OHE IS RESPONSIBLE FOR LEADING PATIENT CARE AND RESEARCH ACTIVITIES INCLUDING THE CANCER HEALTH EQUITY RESEARCH PROGRAM (CHERP) AND CANCER EQUITY PROGRAMS. INTEGRAL TO OHE'S ROLE IS THE DEVELOPMENT OF HEALTH EQUITY RESEARCH AND EDUCATION AND TRAINING. AS SUCH THE OHE HAS IMPLEMENTED RECRUITING AND TRAINING INITIATIVES ACROSS THE INSTITUTION. THE OBJECTIVE OF THESE TRAINING PROGRAMS IS TO ENHANCE THE DIVERSITY OF FUTURE CANCER RESEARCH WORKFORCE BY PROVIDING UNDERREPRESENTED STUDENTS IN MEDICINE WITH EXPOSURE TO CUTTING-EDGE CANCER RESEARCH WITH RENOWNED MENTORS. THE RESEARCH PROGRAM IS FOCUSED ON HAVING DIVERSE POPULATIONS MORE EQUALLY REPRESENTED IN CANCER CLINICAL RESEARCH AND DEVELOPING A BETTER UNDERSTANDING OF THE DIFFERENCES IN CANCER INCIDENCE AND CANCER OUTCOMES EXPERIENCED BY GROUPS TRADITIONALLY UNDERREPRESENTED IN CLINICAL RESEARCH. THE OHE RESEARCH PROGRAM IS ALSO FOCUSED ON INCREASING ENROLLMENT OF UNDERREPRESENTED GROUPS ONTO CLINICAL TRIALS AT MSK. THE OHE PROVIDES FUNDING FOR THESE PROGRAMS ALLOWING UNDERREPRESENTED GROUPS IN MEDICINE OPPORTUNITIES TO PARTICIPATE IN THE NATIONAL CANCER INSTITUTE'S MEDICAL STUDENTS SUMMER PIPELINE PROGRAM. THE OHE ALSO COORDINATES A SIX-WEEK SUMMER EXPOSURE PROGRAM TO EXPOSE HIGH SCHOOL STUDENTS FROM UNDERSERVED COMMUNITIES TO CAREERS IN MEDICINE AND RESEARCH. MEMORIAL SLOAN KETTERING UTILIZED $237.09M OF THE INSTITUTION'S RESOURCES DURING 2022 TO SUPPORT ITS EDUCATION AND TRAINING MISSION, WHICH WE CONSIDER VITAL, GIVEN OUR LEADERSHIP ROLE IN CANCER CARE TREATMENT AND RESEARCH. $55.71M OF THE AMOUNT WAS SPONSORED BY GOVERNMENTAL AND OTHER REVENUE SOURCES AND $181.38M FROM THE INSTITUTION'S GENERAL FUND. THE INSTITUTION HAS A BOARD FOR EACH OF THE SEVEN ENTITIES. AS OUTLINED IN SCHEDULE O, THERE IS A TOTAL OF 116 BOARD MEMBERS. MANY ARE MEMBERS OF MORE THAN ONE ENTITY'S BOARD AND THEREFORE ARE COUNTED MORE THAN ONCE. THE GOVERNING BODY IS COMPRISED OF INDEPENDENT BOARD MEMBERS FROM THROUGHOUT THE UNITED STATES. MSK DOES NOT EXTEND MEDICAL STAFF PRIVILEGES TO COMMUNITY-BASED PHYSICIANS. ALL PHYSICIANS ARE ON STAFF AND ARE EMPLOYEES OF MSK, WITH LIMITED EXCEPTIONS. IN ITS PURSUIT TO FURTHER IMPROVE PATIENT CARE, MEDICAL EDUCATION, AND RESEARCH, THE INSTITUTION REINVESTS ANY SURPLUS FUNDS IN THE INSTITUTION'S POOL OF RESERVES. THESE RESERVES GENERATE INCOME TO SUPPORT FUTURE OPERATIONS AND RESTRICTED FUND SPENDING. BY PROVIDING |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (6 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|
| AMERICAN CANCER SOCIETY | |||||||
| 3380 CHASTAIN MEADOW PKY | KENNESAW | GA | 30144 | 131788491 | 501c(3) | $80,000 | CANCER AWARENESS |
| LEUKEMIA & LYMPHOMA SOCIETY | |||||||
| 3 INTERNATIONAL DR | RYE BROOK | NY | 10573 | 135644916 | 501c(3) | $50,000 | CANCER AWARENESS |
| SUSAN G KOMEN FOR THE CURE | |||||||
| 901 E ST NW | WASHINGTON DC | DC | 20004 | 751835298 | 501c(3) | $27,000 | CANCER AWARENESS |
| LONG ISLAND NETS | |||||||
| 168 39TH STREET | BROOKLYN | NY | 11232 | 222219916 | $15,000 | CANCER AWARENESS | |
| GILDA'S CLUB WESTCHESTER | |||||||
| 80 MAPLE AVE | WHITE PLAINS | NY | 10601 | 133939823 | 501c(3) | $8,000 | CANCER AWARENESS |
| HARLEM SKYSCRAPER CYCLING CLASSIC | |||||||
| 18 MOUNT MORRIS PARK W | NY | NY | 10027 | 501C(3) | $10,000 | CANCER AWARENESS | |
Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Type | STIPENDS | GrantTypeTxt |
| Recipient | 394 | RecipientCnt |
| Cash Grant | $17,816,000 | CashGrantAmt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Form 990, Schedule I | FormAndLineReferenceDesc |
| Explanation | FOR THE YEAR 2022, THE AMOUNT IS FOR STIPENDS PAID TO 183 RESEARCH FELLOWS AND 211 GRADUATE SCHOOL STUDENTS. EDUCATION AND TRAINING INCLUDE CLASSROOM INSTRUCTION WITH HANDS-ON EXPERIENCE IN BOTH RESEARCH LABORATORIES AND CLINICAL CARE ACTIVITIES. THE AFOREMENTIONED GRANTEES ARE REQUIRED TO BE IN COMPLIANCE WITH ACADEMIC REQUIREMENTS. THIS INCLUDES DIRECT SUPERVISION AND DIRECTION BY PHYSICIANS AND RESEARCH INVESTIGATORS. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| First Class Or Charter Travel | Yes (X) | FirstClassOrCharterTravelInd |
| Housing Allowance Or Residence | Yes (X) | HousingAllowanceOrResidenceInd |
| Written Policy Ref T And E Expnss | Yes (true) | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | Yes (true) | SubstantiationRequiredInd |
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (true) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | Yes (true) | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (true) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | Yes (true) | InitialContractExceptionInd |
| Rebuttable Presumption Proc | Yes (true) | RebuttablePresumptionProcInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (25 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt |
|---|---|---|---|---|---|---|---|
| CRAIG B THOMPSON MD | |||||||
| PRESIDENT & CEO-UNTIL 9/22 | $1,786,111 | $6,080,000 | $48,739 | $15,250 | $190,860 | $8,120,960 | $16,000 |
| JASON KLEIN | |||||||
| SVP CHIEF INVESTMENT OFFICER | $1,178,244 | $2,530,000 | $3,099,681 | $24,400 | $51,722 | $6,884,047 | $16,000 |
| MARK BILSKY MD | |||||||
| ATTENDING-NEUROSURGERY | $1,827,832 | $1,500,000 | $24,038 | $24,400 | $35,726 | $3,411,996 | $8,000 |
| BABAK MEHRARA MD | |||||||
| CHIEF ATTENDING-SURGERY | $2,614,193 | $100,000 | $57,755 | $24,400 | $49,219 | $2,845,567 | $8,000 |
| MICHAEL HARRINGTON | |||||||
| EVP & CFO | $1,532,483 | $1,171,000 | $39,797 | $24,400 | $34,595 | $2,802,275 | $8,000 |
| JULIO GARCIA AGUILAR MD | |||||||
| CHIEF ATTENDING-SURGERY | $1,643,890 | $1,050,000 | $34,003 | $24,400 | $49,226 | $2,801,519 | $8,000 |
| JEFFREY DREBIN MD | |||||||
| CHAIRMAN ATTENDNING-SURGERY | $2,452,681 | $200,000 | $69,211 | $24,400 | $51,344 | $2,797,636 | $8,000 |
| KATHRYN MARTIN | |||||||
| EVP & COO | $1,525,357 | $861,318 | $46,861 | $24,400 | $48,553 | $2,506,489 | $16,000 |
| MARTIN WEISER MD | |||||||
| ATTENDING-SURGERY | $1,318,932 | $1,023,077 | $58,304 | $24,400 | $52,931 | $2,477,644 | $8,000 |
| LISA DEANGELIS MD | |||||||
| PHYSICAN IN CHIEF | $1,360,618 | $763,848 | $28,620 | $24,400 | $47,482 | $2,224,968 | $8,000 |
| SIMON POWELL MD | |||||||
| DIRECTOR MSKCC PROTON, INC. | $1,386,898 | $455,364 | $140,636 | $24,400 | $36,812 | $2,044,110 | $8,000 |
| JOAN MASSAGUE PHD | |||||||
| DIRECTOR | $1,102,204 | $520,030 | $177,656 | $24,400 | $45,864 | $1,870,154 | $8,000 |
| KENNETH MANOTTI | |||||||
| SVP DEVELOPMENT | $950,559 | $541,062 | $39,006 | $24,400 | $41,602 | $1,596,629 | $8,000 |
| JORGE LOPEZ ESQ | |||||||
| EVP GENERAL COUNSEL | $1,016,197 | $481,555 | $20,227 | $24,400 | $52,496 | $1,594,875 | $8,000 |
| SELWYN VICKERS MD | |||||||
| PRESIDENT & CEO EFF 9/22 | $862,205 | $500,000 | $4,158 | $15,250 | $43,802 | $1,425,415 | $0 |
| ROXANNE TAYLOR | |||||||
| SVP CHIEF MKT/COMM UNTIL 10/22 | $708,790 | $450,000 | $200,238 | $24,400 | $7,994 | $1,391,422 | $6,415 |
| DEBRA BERNS ESQ | |||||||
| SVP CHIEF RISK OFFICER | $899,983 | $360,000 | $13,690 | $24,400 | $19,331 | $1,317,404 | $8,000 |
| KERRY BESSEY | |||||||
| SVP CHIEF HR OFFICER | $752,352 | $429,270 | $43,312 | $24,400 | $52,020 | $1,301,354 | $16,000 |
| FREDERICK GROVES | |||||||
| EVP HOSPITAL ADMINISTRATION | $679,171 | $322,290 | $54,445 | $24,400 | $36,343 | $1,116,649 | $8,000 |
| REMY EVARD | |||||||
| EVP & CHIEF DIGIT OFF EFF 1/22 | $795,472 | $100,000 | $78,902 | $16,202 | $35,854 | $1,026,430 | $0 |
| MARK SVENNINGSON | |||||||
| SVP FINANCE | $736,994 | $175,003 | $32,685 | $24,400 | $36,566 | $1,005,648 | $16,000 |
| ERIN MCDONOUGH | |||||||
| SVP CH MKT/COMM OFF EFF 10/22 | $712,670 | $50,000 | $5,291 | $24,400 | $16,944 | $809,305 | $0 |
| CAROLYN LEVINE ESQ | |||||||
| DEPUTY GEN COUNSEL | $464,068 | $89,116 | $17,868 | $15,250 | $31,787 | $618,089 | $7,780 |
| AMADOR CENTENO | |||||||
| SVP REAL ESTATE DEVLP EFF 7/22 | $347,732 | $0 | $35,073 | $24,034 | $1,592 | $408,431 | $0 |
| MARGARET BURKE | |||||||
| DIRECTOR, MSKCC PROTON, INC. | $563,177 | $216,500 | $51,538 | $24,400 | $52,082 | $907,697 | $16,000 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Supplemental Compensation Information | FormAndLineReferenceDesc |
| Explanation | SCHEDULE J, PART I, LINE 1A BUSINESS OR FIRST-CLASS TRAVEL IS ALLOWED FOR FLIGHTS GREATER THAN SIX CONTINUOUS HOURS FOR ANY EMPLOYEE NOT FUNDED BY FEDERAL GRANTS. EXCEPTIONS TO THE SIX HOUR RULE ARE REVIEWED ON AN INDIVIDUAL BASIS. ALL TRAVEL MUST BE APPROVED BEFORE ANY ARRANGEMENTS ARE MADE. MSKCC HAS AN ACCOUNTABLE TRAVEL POLICY AND THEREFORE, DOES NOT INCLUDE TRAVEL AS TAXABLE COMPENSATION. THE INSTITUTION REQUIRES THE PRESIDENT TO BE ON CALL AND TO PERFORM DUTIES AS AND WHEN APPROPRIATE DURING OFF-DUTY PERIODS AS WELL AS DURING NORMAL OFFICE HOURS. AN EMPLOYMENT CONTRACT REQUIRES OUR PRESIDENT TO LIVE IN THE OFFICIAL RESIDENCE OWNED AND MAINTAINED BY THE INSTITUTION. THE CONTRACT REQUIRES OUR PRESIDENT TO USE THE RESIDENCE FOR INSTITUTIONAL PURPOSES, INCLUDING, BUT NOT LIMITED TO, MEETINGS WITH STAFF, DONORS AND POTENTIAL DONORS, VISITING PROFESSORS AND SCIENTISTS, AND OTHER PERSONS INVOLVED WITH THE AFFAIRS OF THE INSTITUTION, CONFIDENTIAL INTERVIEWS WITH MEMBERS AND PROSPECTIVE MEMBERS OF THE STAFF; AND FOR OTHER INSTITUTIONAL ACTIVITIES CONDUCTED DURING AND OUTSIDE OF NORMAL OFFICE HOURS. THE COST IS REPORTED AS COMPENSATION ON FORM 990 AND IS EXCLUDED FROM TAXABLE COMPENSATION IN ACCORDANCE WITH CODE SECTION 119. SCHEDULE J, PART I LINE 4A - INCLUDED IN FORM 990 IS SEVERANCE PAY: PHILLIP KANTOFF MD., CHAIRMAN ATTENDING $1,250,040 TERMINATED IN 2021. ROXANNE TAYLOR, SVP, CHIEF MARKETING & COMMUNICATIONS OFFICER $179,567 TERMINATED 2022 LINE 4b-INCLUDED IN FORM 990: JASON KLEIN WAS PAID $2,980,253 AS PART OF A DEFERRED COMPENSATION AGREEMENT. LINE 7 - INCENTIVE PAY IS PROVIDED TO OFFICERS AND KEY EMPLOYEES BASED ON THEIR ACHIEVEMENT OF PRE-DETERMINED GOALS RELATING TO QUALITY OF CARE, PATIENT SAFETY, OPERATIONAL EFFICIENCY AND FINANCIAL PERFORMANCE. THE COMPENSATION COMMITTEE OF THE BOARD AUTHORIZES ALL EXECUTIVE BONUSES AND INCENTIVE PLANS ON AN ANNUAL BASIS. LINE 8 - AN EMPLOYMENT CONTRACT WAS ENTERED INTO AND SIGNED PRIOR TO EMPLOYMENT. | ExplanationTxt |
Schedule K IRS990ScheduleK
Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp (4 entries)
| Bond ReferenceBondReferenceCd | Bond Issuer EINBondIssuerEIN | CUSIPCUSIPNum | Bond IssuedBondIssuedDt | Issue PriceIssuePriceAmt | PurposePurposeDesc | DefeasedDefeasedInd | On Behalf Of IssuerOnBehalfOfIssuerInd | Pool FinancingPoolFinancingInd |
|---|---|---|---|---|---|---|---|---|
| DORMITORY AUTHORITY OF THE STATE OF NEW YORK | ||||||||
| A | 146000293 | 6499063Z7 | 2013-06-28 | $80,000,000 | SEE PART VI | false | false | false |
| DORMITORY AUTHORITY OF THE STATE OF NEW YORK | ||||||||
| B | 146000293 | 000000000 | 2016-04-28 | $110,000,000 | SEE PART VI | false | false | false |
| NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY | ||||||||
| C | 222045817 | 000000000 | 2016-09-09 | $145,000,000 | SEE PART VI | false | false | false |
| DOMITORY AUTHORITY OF THE STATE OF NEW YORK | ||||||||
| D | 146000293 | 000000000 | 2017-12-20 | $335,567,386 | SEE PART VI | false | false | false |
Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp (4 entries)
| Bond ReferenceBondReferenceCd | RetiredRetiredAmt | Bond DefeasedBondDefeasedAmt | Total ProceedsTotalProceedsAmt | In Reserve FundInReserveFundAmt | Capitalized InterestCapitalizedInterestAmt | Refunding EscrowRefundingEscrowAmt | Issuance Costs From ProceedsIssuanceCostsFromProceedsAmt | Credit EnhancementCreditEnhancementAmt | Working Capital ExpendituresWorkingCapitalExpendituresAmt | Capital ExpendituresCapitalExpendituresAmt | Other Spent ProceedsOtherSpentProceedsAmt | UnspentUnspentAmt | Substantial CompletionSubstantialCompletionYr | Refunding Tax Exempt BondsRefundingTaxExemptBondsInd | Refunding Taxable BondsRefundingTaxableBondsInd | Final Allocation MadeFinalAllocationMadeInd | Adequate Books And Rec MaintAdequateBooksAndRecMaintInd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | $74,000,000 | $0 | $80,000,000 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $80,000,000 | $0 | 2013 | Yes (true) | false | Yes (true) | Yes (true) |
| B | $18,702,374 | $0 | $110,239,999 | $0 | $0 | $0 | $155,282 | $0 | $0 | $110,009,717 | $75,000 | $0 | 2017 | false | false | Yes (true) | Yes (true) |
| C | $76,125,000 | $0 | $145,000,000 | $0 | $0 | $0 | $72,861 | $0 | $0 | $144,627,139 | $300,000 | $0 | 2018 | false | false | Yes (true) | Yes (true) |
| D | $11,550,000 | $0 | $339,194,534 | $0 | $0 | $0 | $2,262,236 | $0 | $0 | $245,499,309 | $91,432,989 | $0 | 2019 | Yes (true) | false | Yes (true) | Yes (true) |
Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp (4 entries)
| Bond ReferenceBondReferenceCd | Owning Bond Financed PropertyOwningBondFinancedPropertyInd | Any Lease ArrangementsAnyLeaseArrangementsInd | Mgmt Contract Bond Fincd PropMgmtContractBondFincdPropInd | Any Research AgreementsAnyResearchAgreementsInd | Engage Bond Counsel ResearchEngageBondCounselResearchInd | Private Bus Use By OthersPrivateBusUseByOthersPct | Private Bus Concerning UBIPrivateBusConcerningUBIPct | Total Private Business UseTotalPrivateBusinessUsePct | Bond Iss Meet Prvt Sec Pymt TestBondIssMeetPrvtSecPymtTestInd | Change In Use Bond Financed PropChangeInUseBondFinancedPropInd | Change In Use Bond Financed PropChangeInUseBondFinancedPropPct | Remedial Action TakenRemedialActionTakenInd | Procs Nonqualified Bond RemdtdProcsNonqualifiedBondRemdtdInd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | false | false | false | Yes (true) | false | 0.00000 | 0.00000 | 0.00000 | false | false | 0.00000 | false | Yes (true) |
| B | false | false | false | Yes (true) | false | 0.00000 | 0.00000 | 0.00000 | false | false | 0.00000 | false | Yes (true) |
| C | false | false | false | Yes (true) | false | 0.00000 | 0.00000 | 0.00000 | false | false | 0.00000 | false | Yes (true) |
| D | false | false | false | Yes (true) | false | 0.00000 | 0.00000 | 0.00000 | false | false | 0.00000 | false | Yes (true) |
Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp (4 entries)
| Bond ReferenceBondReferenceCd | Form8038 T FiledForm8038TFiledInd | Rebate Not Due YetRebateNotDueYetInd | Exception To RebateExceptionToRebateInd | No Rebate DueNoRebateDueInd | Variable Rate IssueVariableRateIssueInd | Hedge Identified In Bks And RecHedgeIdentifiedInBksAndRecInd | Gross Proceeds Invested In GICGrossProceedsInvestedInGICInd | Business Name Line1GICProviderName/BusinessNameLine1Txt | Gross Proceeds InvestedGrossProceedsInvestedInd | Written Proc To Monitor ReqsWrittenProcToMonitorReqsInd |
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | ||||||||||
| A | false | false | false | Yes (true) | false | false | false | 0 | false | Yes (true) |
| 0 | ||||||||||
| B | false | false | false | Yes (true) | false | false | false | 0 | false | Yes (true) |
| 0 | ||||||||||
| C | false | false | false | Yes (true) | false | false | false | 0 | false | Yes (true) |
| 0 | ||||||||||
| D | false | false | false | Yes (true) | false | false | false | 0 | false | Yes (true) |
Procedures Corrective Action ProceduresCorrectiveActionGrp (4 entries)
| Bond ReferenceBondReferenceCd | Procedures Corrective ActionProceduresCorrectiveActionInd |
|---|---|
| A | Yes (true) |
| B | Yes (true) |
| C | Yes (true) |
| D | Yes (true) |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, COLUMN (F) DESCRIPTION OF PURPOSE | FormAndLineReferenceDesc |
| Explanation | 2013 SERIES BONDS (DASNY)- CUSIP #6499063Z7: 2013 SERIES BONDS WERE USED TO CURRENT REFUND THE 2010 SERIES BONDS ISSUED 9/2/2010. 2016 SERIES BONDS (DASNY) - CUSIP #000000000: 2016 SERIES BONDS WERE USED TO CONSTRUCT/RENOVATE AND UPGRADE AND EQUIP VARIOUS FACILITIES. 2016 SERIES BONDS (NJEDA) - CUSIP #000000000: 2016 SERIES BONDS WERE USED TO CONSTRUCT AND EQUIP VARIOUS FACILITIES. 2017 SERIES BONDS (DASNY)- CUSIP #000000000: 2017 SERIES BONDS WERE USED TO CURRENT REFUND THE 2015 SERIES BONDS ISSUED JULY 16, 2015 AND CONSTRUCT VARIOUS FACILITIES. 2019 SERIES BONDS (DASNY) - CUSIP #64990GVG4: 2019 SERIES BONDS WERE USED TO REIMBURSE EXPENDITURES INCURRED TO CONSTRUCT A PATIENT CARE FACILITY. 2022 SERIES #1 BONDS (DASNY) - CUSIP #65000BPS1: 2022 SERIES #1 BONDS WERE USED TO RENOVATE VARIOUS LOCATIONS - HOSPITAL AND OUTPATIENT FACILITIES AND REPLACE MACHINERY EQUIPMENT. 2022 SERIES #2 BONDS (DASNY) - CUSIP #000000000: 2022 SERIES #2 BONDS WERE USED TO RENOVATE NON-PATIENT SPACE. PART II LINE 3 - THE AMOUNT OF PROCEEDS ON PART II LINE 3 IS DIFFERENT FROM PART I COLUMN (E) BECAUSE PART II LINE 3 INCLUDES INVESTMENT INCOME AND GAINS/LOSSES. PART III LINE 3(D) - ANY MANAGEMENT CONTRACTS AND RESEARCH AGREEMENTS THAT MAY RESULT IN PRIVATE BUSINESS USE OF BONDS FINANCED PROPERTIES ARE REVIEWED FIRST BY IN-HOUSE STAFF WHO ARE KNOWLEDGEABLE OF AND RESPONSIBLE FOR THE FORM 990. OUTSIDE COUNSEL IS CONSULTED IF QUESTIONS ARISE. PART IV LINE 2(C) THE DASNY 2013 SERIES BONDS REBATE CALCULATIONS WERE LAST PERFORMED ON JUNE 21, 2019. THE DASNY 2016 SERIES BONDS REBATE CALCULATIONS WERE PERFORMED ON MAY 19, 2023. THE NJEDA 2016 SERIES BONDS REBATE CALCULATIONS WERE PERFORMED ON JULY 6, 2022. THE DASNY 2017 SERIES BONDS REBATE CALCULATIONS WERE PERFORMED ON MARCH 17, 2023. | ExplanationTxt |
Schedule K IRS990ScheduleK
Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp (3 entries)
| Bond ReferenceBondReferenceCd | Bond Issuer EINBondIssuerEIN | CUSIPCUSIPNum | Bond IssuedBondIssuedDt | Issue PriceIssuePriceAmt | PurposePurposeDesc | DefeasedDefeasedInd | On Behalf Of IssuerOnBehalfOfIssuerInd | Pool FinancingPoolFinancingInd |
|---|---|---|---|---|---|---|---|---|
| DORMITORY AUTHORITY OF THE STATE OF NEW YORK | ||||||||
| A | 146000293 | 64990GVG4 | 2019-11-01 | $342,248,699 | SEE PART VI | false | false | false |
| Dormitory Authority of the State of New York | ||||||||
| B | 146000293 | 65000BPS1 | 2022-06-28 | $199,996,589 | SEE PART VI | false | false | false |
| Dormitory Authority of the State of New York | ||||||||
| C | 146000293 | 000000000 | 2022-08-01 | $100,000,000 | SEE PART VI | false | false | false |
Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp (3 entries)
| Bond ReferenceBondReferenceCd | RetiredRetiredAmt | Bond DefeasedBondDefeasedAmt | Total ProceedsTotalProceedsAmt | In Reserve FundInReserveFundAmt | Capitalized InterestCapitalizedInterestAmt | Refunding EscrowRefundingEscrowAmt | Issuance Costs From ProceedsIssuanceCostsFromProceedsAmt | Credit EnhancementCreditEnhancementAmt | Working Capital ExpendituresWorkingCapitalExpendituresAmt | Capital ExpendituresCapitalExpendituresAmt | Other Spent ProceedsOtherSpentProceedsAmt | UnspentUnspentAmt | Substantial CompletionSubstantialCompletionYr | Refunding Tax Exempt BondsRefundingTaxExemptBondsInd | Refunding Taxable BondsRefundingTaxableBondsInd | Final Allocation MadeFinalAllocationMadeInd | Adequate Books And Rec MaintAdequateBooksAndRecMaintInd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | $0 | $0 | $342,248,699 | $0 | $0 | $0 | $2,248,699 | $0 | $0 | $340,000,000 | $0 | $0 | 2019 | false | false | Yes (true) | Yes (true) |
| B | $0 | $0 | $200,507,663 | $0 | $0 | $0 | $1,220,622 | $0 | $0 | $199,162,041 | $125,000 | $0 | 2022 | false | false | Yes (true) | Yes (true) |
| C | $0 | $0 | $101,054,264 | $0 | $0 | $0 | $227,400 | $0 | $0 | $23,057,369 | $15,000 | $77,754,495 | false | false | false | Yes (true) |
Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp (3 entries)
| Bond ReferenceBondReferenceCd | Owning Bond Financed PropertyOwningBondFinancedPropertyInd | Any Lease ArrangementsAnyLeaseArrangementsInd | Mgmt Contract Bond Fincd PropMgmtContractBondFincdPropInd | Any Research AgreementsAnyResearchAgreementsInd | Engage Bond Counsel ResearchEngageBondCounselResearchInd | Private Bus Use By OthersPrivateBusUseByOthersPct | Private Bus Concerning UBIPrivateBusConcerningUBIPct | Total Private Business UseTotalPrivateBusinessUsePct | Bond Iss Meet Prvt Sec Pymt TestBondIssMeetPrvtSecPymtTestInd | Change In Use Bond Financed PropChangeInUseBondFinancedPropInd | Change In Use Bond Financed PropChangeInUseBondFinancedPropPct | Remedial Action TakenRemedialActionTakenInd | Procs Nonqualified Bond RemdtdProcsNonqualifiedBondRemdtdInd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | false | false | false | Yes (true) | false | 0.00000 | 0.00000 | 0.00000 | false | false | 0.00000 | false | Yes (true) |
| B | false | false | false | Yes (true) | false | 0.00000 | 0.00000 | 0.00000 | false | false | 0.00000 | false | Yes (true) |
| C | false | false | false | Yes (true) | false | 0.00000 | 0.00000 | 0.00000 | false | false | 0.00000 | false | Yes (true) |
Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp (3 entries)
| Bond ReferenceBondReferenceCd | Form8038 T FiledForm8038TFiledInd | Rebate Not Due YetRebateNotDueYetInd | Exception To RebateExceptionToRebateInd | No Rebate DueNoRebateDueInd | Variable Rate IssueVariableRateIssueInd | Hedge Identified In Bks And RecHedgeIdentifiedInBksAndRecInd | Gross Proceeds Invested In GICGrossProceedsInvestedInGICInd | Business Name Line1GICProviderName/BusinessNameLine1Txt | Gross Proceeds InvestedGrossProceedsInvestedInd | Written Proc To Monitor ReqsWrittenProcToMonitorReqsInd |
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | ||||||||||
| A | false | Yes (true) | false | false | false | false | false | 0 | false | Yes (true) |
| 0 | ||||||||||
| B | false | Yes (true) | false | false | false | false | false | 0 | false | Yes (true) |
| 0 | ||||||||||
| C | false | Yes (true) | false | false | false | false | false | 0 | false | Yes (true) |
Procedures Corrective Action ProceduresCorrectiveActionGrp (3 entries)
| Bond ReferenceBondReferenceCd | Procedures Corrective ActionProceduresCorrectiveActionInd |
|---|---|
| A | Yes (true) |
| B | Yes (true) |
| C | Yes (true) |
Schedule L IRS990ScheduleL
Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp (3 entries)
| Relationship DescriptionRelationshipDescriptionTxt | TransactionTransactionAmt | TransactionTransactionDesc | Sharing Of RevenuesSharingOfRevenuesInd |
|---|---|---|---|
| DR T LINDSTEN | |||
| SEE PART V BELOW | $318,446 | FAMILY EMPLOYMENT | false |
| MEMORIAL MEDICAL CARE PC | |||
| SEE PART V | $541,000 | MANAGEMENT AGREEMENT | false |
| JESSICA STUART | |||
| SEE PART V | $21,411 | FAMILY EMPLOYMENT | false |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Business transactions with interested parties | FormAndLineReferenceDesc |
| Explanation | 1. DR. CRAIG THOMPSON WAS THE PRESIDENT OF THE INSTITUTION UNTIL SEPTEMBER 2022. HIS SPOUSE, DR. TULLIA LINDSTEN, IS A LABORATORY MEMBER FOR SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH. HER COMPENSATION, FOR 2022 WAS $318,446 2. DR. LISA DEANGELIS IS THE PHYSICIAN-IN -CHIEF OF THE ORGANIZATION. IN SUCH A CAPACITY, SHE IS A 75% OWNER OF MEMORIAL MEDICAL CARE PC (MMPC). MMPC IS A SECTION 501(C)(3) TAX-EXEMPT CAPTIVE MEDICAL GROUP. MMPC OPERATES A FACILITY IN BROOKLYN WHERE PATIENTS HAVE ACCESS TO A WIDE RANGE OF SERVICES, INCLUDING ADVANCED IMAGING, STATE-OF THE-ART THERAPIES, CUTTING-EDGE CLINICAL TRIALS, AND A MULTIDISCIPLINARY TEAM OF SPECIALISTS. THE AMOUNT REPORTED IN PART IV, $541,000, IS THE NET COSTS FOR SUCH SERVICES IN 2022. 3. SCOTT STUART IS A BOARD MEMBER OF MEMORIAL HOSPITAL, HIS DAUGHTER, JESSICA STUART, IS AN INSTRUCTOR AT MEMORIAL HOSPITAL. HER COMPENSATION FOR 2022 WAS $21,411 THE INDIVIDUALS LISTED WERE NOT A PARTY TO THE TRANSACTIONS. THERE IS NO SHARING OF THE INSTITUTE'S REVENUE. THE PURCHASE OF GOODS AND SERVICES BY THE INSTITUTION WERE MADE IN THE ORDINARY COURSE OF THE PROVIDER'S BUSINESS, AT COMMERCIALLY AVAILABLE RATES NORMALLY CHARGED TO OTHERS | ExplanationTxt |
Schedule M IRS990ScheduleM
| Field | Value | IRS element (for citing) |
|---|---|---|
| Works Of Art | WorksOfArtGrp | |
| Art Historical Treasures | ArtHistoricalTreasuresGrp | |
| Art Fractional Interest | ArtFractionalInterestGrp | |
| Books And Publications | BooksAndPublicationsGrp | |
| Clothing And Household Goods | ClothingAndHouseholdGoodsGrp | |
| Cars And Other Vehicles | CarsAndOtherVehiclesGrp | |
| Boats And Planes | BoatsAndPlanesGrp | |
| Intellectual Property | IntellectualPropertyGrp |
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 173 | ContributionCnt |
| Noncash Contributions Rpt F990 | $12,032,474 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | MARKET VALUE | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities Closely Held Stock | SecuritiesCloselyHeldStockGrp | |
| Secur Prtnrshp Trust Intrsts | SecurPrtnrshpTrustIntrstsGrp | |
| Securities Miscellaneous | SecuritiesMiscellaneousGrp | |
| Qualified Contrib Hist Struct | QualifiedContribHistStructGrp | |
| Qualified Contrib Other | QualifiedContribOtherGrp | |
| Real Estate Residential | RealEstateResidentialGrp | |
| Real Estate Commercial | RealEstateCommercialGrp | |
| Real Estate Other | RealEstateOtherGrp | |
| Collectibles | CollectiblesGrp | |
| Food Inventory | FoodInventoryGrp | |
| Drugs And Medical Supplies | DrugsAndMedicalSuppliesGrp | |
| Taxidermy | TaxidermyGrp | |
| Historical Artifacts | HistoricalArtifactsGrp | |
| Scientific Specimens | ScientificSpecimensGrp | |
| Archaeological Artifacts | ArchaeologicalArtifactsGrp | |
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (true) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | Yes (true) | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I | FormAndLineReferenceDesc |
| Explanation | PUBLICLY TRADED DONATED STOCK IS SOLD BY MERRILL LYNCH ON BEHALF OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATED ORGANIZATIONS. LINE 9 (B) NUMBER OF CONTRIBUTUINS | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (8 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART VI, LINE 2 | FOR THE TAX YEAR 2022, THE FOLLOWING BUSINESS RELATIONSHIPS WERE REPORTED: 1. DIRECTORS ELLEN V. FUTTER AND PETER J. SOLOMON 2. DIRECTORS ELLEN V. FUTTER AND RICHARD I. BEATTIE |
| PART VI, LINES 6-7 | THE ARTICLES OF INCORPORATION AND BY-LAWS WERE REVIEWED TO DETERMINE THAT THE SUPPORTED ORGANIZATIONS OUTLINED IN SCHEDULE-A HAVE THE POWER TO ELECT OR APPOINT MEMBERS TO THE BOARD OF THE SUPPORTING ORGANIZATIONS. MEMORIAL SLOAN-KETTERING CANCER CENTER, EIN 13-1924236, (MSK), IS THE SINGLE MEMBER OF THE PROSTATE CANCER CLINICAL TRIALS CONSORTIUM LLC, PCCTC, WHICH HAS ELECTED TO BE TREATED AS A DISREGARDED ENTITY OF MSK FOR TAX PURPOSES AND MSKCC PROTON, INC. WHICH IS ALSO TREATED AS A CORPORATION FOR TAX PURPOSES. MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES EIN 13-1624082, (MEM), IS THE SINGLE MEMBER OF MSKCC PROPERTIES LLC, WHO HAS ELECTED TO BE TREATED AS A CORPORATION FOR TAX PURPOSES. |
| PART VI, LINE 11B | PRIOR TO FILING THE RETURN, A REVIEW OF THE 990 WAS CONDUCTED BY THE SR. VP OF FINANCE AND THE CHIEF FINANCIAL OFFICER. IT IS THEN PRESENTED TO, AND REVIEWED BY, THE JOINT AUDIT COMMITTEE OF THE BOARD. THE JOINT AUDIT COMMITTEE REFERS THE FORM 990 TO THE FULL BOARD, AND A COPY IS PROVIDED TO EACH BOARD MEMBER FOR FURTHER REVIEW. MEMORIAL SLOAN-KETTERING'S FORM 990 IS REVIEWED BY COUNSEL AND IS PREPARED IN CONJUNCTION WITH ERNST AND YOUNG, LLP. |
| PART VI, LINE 12C | In 2022, MSK's conflict of interest (COI) program was implemented through three comprehensive policies for Memorial Sloan Kettering Cancer Center, Memorial Hospital for Cancer and Allied Diseases and Sloan-Kettering Institute for Cancer Research, which are outlined below: 1. Conflict of Interest and Commitment Policy (the "Individual COI Policy"). a. The Individual COI Policy applied to: (i) physicians and scientists with academic appointments at any level; (ii) any clinical provider who could independently write orders or prescriptions; (iii) individuals whose roles included the design, conduct or reporting of research and/or were engaged in human subject research; (iv) administrative employees with independent authority to make purchasing decisions or who were otherwise able to bind, negotiate on behalf, or execute agreements on behalf of, MSK; and (v) individuals that served on MSK institutional committees with responsibility for oversight of research, formulary, or purchasing decisions. b. MSK's Compliance COI Office ("Compliance") and the institutional conflict of interest committee (the "MSK COI Committee") were responsible for the administration of this policy, under the oversight of the committee of the Board (the "Board COI Committee") dedicated exclusively to discharging the Board's responsibility and authority over MSK's conflicts of interest program. c. Upon becoming covered by the Individual COI Policy, annually thereafter and/or as new significant interests arose, an individual was required to disclose financial interests and external relationships and activities ("interests"), whether paid or unpaid, that reasonably appeared to be related to the individual's institutional responsibilities. Covered Persons were required to disclose interests for themselves and immediate family members. d. Depending on the circumstances and based on established criteria, disclosed interests were reviewed by Compliance, the MSK COI Committee, MSK COI Committee designee(s), and/or the Board COI Committee to determine whether an individual conflict of interest existed or presented the perception thereof (i.e. whether an individual financial interest could directly and significantly impact an individual's institutional responsibilities, or an individual's interest could be directly and significantly impacted by their institutional responsibilities). e. The policy required any individual conflict of interest to be managed, reduced or eliminated. When a conflict of interest determination was made, the MSK COI Committee, the MSK COI Committee designee(s), or the Board COI Committee, as applicable, determined how to address it. For those conflicts deemed manageable, management strategies implemented included disclosure of the interest in relevant publications, presentations, consent forms, and educational materials; recusal and/or other limitation on role; independent oversight by a disinterested senior personnel member or committee; and temporary or permanent reduction, divestiture, relinquishment, or termination of an individual's interest. 2. Institutional Conflict of Interest Policy (the "Institutional COI Policy"). a. The Institutional COI Policy applied to financial interests and relationships ("interests") held by MSK as an institution, as well as those financial interests and relationships ("interests") held by five senior executive officers deemed "Institutional Officials,their immediate family members. Institutional Officials included the President and Chief Executive Officer, the Physician-In-Chief and Chief Medical Officer, the Chief Operating Officer, the Chief Financial Officer, and the Director of the Sloan-Kettering Institute for Cancer Research. b. Institutional interests held by MSK were made available to Compliance through regular reports from and ongoing engagement with relevant MSK departments. Institutional interests held by Institutional Officials were disclosed through the process described above in the Individual COI Policy, as well as the process described below in the Board COI Policy. c. The MSK COI Committee or MSK COI Committee designee(s) were responsible for determining whether an institutional conflict of interest existed; i.e. whether the institutional interest held by MSK or an Institutional Official (or their immediate family members) could, or could reasonably be perceived to, directly and significantly affect the design, conduct, reporting, review, or oversight of MSK research or the outcome of an MSK activity or decision. d. The policy required any institutional conflict of interest to be managed, reduced or eliminated. When an institutional conflict of interest determination was made, the MSK COI Committee and/or the MSK COI Committee designee(s) determined how to address it. For those conflicts deemed manageable, management strategies implemented included recusal of the applicable Institutional Official from decision-making regarding the arrangement and disclosure to relevant personnel; disclosure of the interest in relevant publications, presentations, consent forms, and educational materials; independent oversight by a disinterested senior personnel member or committee; and temporary or permanent reduction, divestiture, relinquishment, or termination of MSK's or an Institutional Official's institutional interest. 3. Boards of Governing Trustees Conflict of Interest Policy (the "Board COI Policy"). a. The Board COI Policy applied to Board members, officers, and other MSK senior leadership. Individuals covered by the Board COI Policy were required to disclose financial interests and relationships, as defined by the policy, annually and on an ongoing basis. Other entities in the same tax-exempt group had overlapping officers and Board members as described in Schedule O; such persons reported financial interests through this or related processes. b. The Board COI Committee was responsible for determining whether any interest disclosed under the Board COI Policy gave rise to a conflict of interest. The policy required that the members of the Board COI Committee vote, without the individual with the potential conflict present, to determine whether a conflict of interest existed. All members participating in the vote were required to be disinterested with respect to the transaction, arrangement, or relationship. c. The covered individual with the conflict of interest could make a presentation to the Board COI Committee, but could not participate in or influence the discussion of, or vote on, the proposed transaction, arrangement, or relationship. The existence and resolution of any conflict of interest, along with associated determinations made and votes taken, were required to be documented in writing. d. For any transaction, arrangement, or relationship that involved a conflict of interest, a conflict management plan could be implemented if doing so was in the best interests of MSK. Management plans could require disclosure, recusal or other limitation of role, independent oversight and confidentiality. |
| PART VI, LINE 15 | MEMORIAL SLOAN-KETTERING CANCER CENTER (MSKCC) IS COMMITTED TO ENSURING THAT ITS EXECUTIVE COMPENSATION PROGRAM ADHERES TO THE ESTABLISHED STANDARDS OF REGULATORY COMPLIANCE AND BEST CORPORATE GOVERNANCE. THE MSKCC BOARD OF TRUSTEES AND GOVERNING TRUSTEES HAS CHARGED THE JOINT HUMAN RESOURCES COMMITTEE (WHICH IS COMPOSED ENTIRELY OF INDEPENDENT BOARD MEMBERS WITH NO CONFLICTS OF INTEREST IN REGARD TO EXECUTIVE COMPENSATION) WITH MAKING ALL DECISIONS RELATED TO COMPENSATION FOR OFFICERS AND KEY EMPLOYEES. THE COMMITTEE REVIEWS THE TOTAL COMPENSATION OF THE INDIVIDUALS, INCLUDING BOTH CURRENT AND DEFERRED COMPENSATION, AND ALL EMPLOYEE BENEFITS, ON AN ANNUAL BASIS TO ENSURE THAT THE TOTAL COMPENSATION OF EACH OFFICER AND KEY EMPLOYEE IS REASONABLE. TO ASSIST IN THE COMPLETION OF ITS RESPONSIBILITIES, THE COMMITTEE ENGAGES THE SERVICES OF A NATIONALLY RECOGNIZED CONSULTING FIRM SPECIALIZING IN EXECUTIVE COMPENSATION FOR NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS. EACH YEAR THE COMMITTEE REVIEWS A COMPREHENSIVE REPORT PREPARED BY THE FIRM THAT INCLUDES MARKET DATA FOR FUNCTIONALLY COMPARABLE ROLES IN COMPARABLE ORGANIZATIONS (I.E., NOT-FOR-PROFIT ACADEMIC/RESEARCH MEDICAL CENTERS, ESPECIALLY THOSE SHARING A MISSION SIMILAR TO MSKCC, WITH OTHER HEALTHCARE SECTORS CONSIDERED ON A SELECTED BASIS) AND SUMMARIZES THE RELATIVE MARKET POSITION OF EACH EXECUTIVE'S TOTAL COMPENSATION. THE LAST REVIEW WAS MARCH 2022, WHICH SET THE COMPENSATION FOR THE PERIOD APRIL 2022 TO MARCH 2023. ADDITIONALLY, A SENIOR MEMBER OF THE CONSULTING FIRM ATTENDS COMMITTEE MEETINGS TO PROVIDE INFORMATION AND TO RESPOND TO QUESTIONS BY THE MEMBERS OF THE COMMITTEE. COMPENSATION LEVELS ARE ESTABLISHED CONSIDERING THE MARKET DATA, AN ASSESSMENT OF PERFORMANCE, AND OTHER BUSINESS JUDGMENT FACTORS, CONSISTENT WITH MSKCC'S EXECUTIVE COMPENSATION PHILOSOPHY. THE COMMITTEE'S DECISIONS ARE MADE IN THE BEST INTERESTS OF MSKCC AND ARE INTENDED TO ENSURE THE RECRUITMENT AND RETENTION OF KEY EXECUTIVE TALENT, CONSISTENT WITH THE MARKET PRACTICES OF OTHER NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS OF COMPARABLE SCOPE, MISSION AND COMPLEXITY. THE COMMITTEE'S REVIEW PROCESS FOLLOWS THE INTERMEDIATE SANCTIONS GUIDELINES FOR QUALIFYING FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986: - THE COMPENSATION ARRANGEMENT IS APPROVED IN ADVANCE BY AN "AUTHORIZED BODY" OF THE APPLICABLE TAX EXEMPT ORGANIZATION (I.E, THE COMMITTEE, WHICH IS COMPOSED ENTIRELY OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITHIN THE MEANING OF THE REGULATIONS UNDER SECTION 4958). - THE AUTHORIZED BODY OBTAINS AND RELIES UPON "APPROPRIATE DATA AS TO COMPARABILITY" PRIOR TO MAKING ITS DETERMINATION, FOR WHICH COMPARABILITY DATA ARE PROVIDED AND ANALYZED BY SULLIVAN, COTTER AND ASSOCIATES, INC., A WELL-REGARDED EXPERT IN THE AREA OF HEALTHCARE COMPENSATION. - THE COMMITTEE ADEQUATELY DOCUMENTS THE BASIS FOR ITS DETERMINATION CONCURRENTLY WITH MAKING THAT DETERMINATION, AGAIN AS REQUIRED IN THE REGULATIONS. |
| PART VI, LINE 19 | THE INSTITUTION HAS ENGAGED DAC BOND AS OUR INVESTOR RELATIONS AND DISCLOSURE/DISSEMINATION AGENT. COPIES OF OUR IRS FORM 990, 990T AND OUR AUDITED FINANCIAL STATEMENTS, QUARTERLY UNAUDITED FINANCIAL STATEMENTS, AND THE BOND OFFERING STATEMENTS FOR ALL OUR DEBT ISSUES ARE AVAILABLE ON THEIR WEB ADDRESS: WWW.DACBOND.COM. THE CONFLICT OF INTEREST AND COMMITMENT POLICY IS ACCESSIBLE ON OUR INSTITUTIONAL WEB SITE: WWW.MSKCC.ORG. HOWEVER, OUR GOVERNING DOCUMENTS SUCH AS THE ARTICLES OF INCORPORATION AND CORPORATE BY-LAWS ARE NOT AVAILABLE FOR PUBLIC INFORMATION. |
| PART VII, SECTION A | THIS IRS FORM 990 IS FILED UNDER GROUP EXEMPTION NUMBER 3475, EIN 91-2154267. THE ATTACHED LIST REPRESENTS MEMBERS FROM THE GOVERNING BOARDS OF THE FOLLOWING AFFILIATED INSTITUTIONS THAT MAKE UP OUR EXEMPT GROUP: MEMORIAL SLOAN-KETTERING CANCER CENTER (MSK) EIN 13-1924236, MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (MEM) EIN 13-1624082, SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (SKI) EIN 13-1624182, S.K.I. REALTY, INC. (SKR) EIN 13-3389586, LOUIS V. GERSTNER JR. GRADUATE SCHOOL OF BIOMEDICAL SCIENCES (SKG) EIN 20-2212588, MSK INSURANCE US, INC. (MVI) EIN 83-0363317, AND MSKCC PROTON INC.,(MPI) EIN 35-2397819. ALSO INCLUDED IN THE GROUP IS MSK PROPERTIES LLC. EIN 35-2464610 WITH MEMORIAL HOSPITAL BEING THE SOLE MEMBER. MEMORIAL SLOAN KETTERING BOARD OF GOVERNING TRUSTEES: RICHARD I. BEATTIE IAN COOK, VICE CHAIR OF THE BOARD (A) STANLEY F. DRUCKENMILLER ANTHONY B. EVNIN ROGER W. FERGUSON HENRY A. FERNANDEZ WILLIAM E. FORD RICHARD N. FOSTER STEPHEN FRIEDMAN ELLEN V. FUTTER LOUIS V. GERSTNER, JR. JONATHAN N. GRAYER BENJAMIN W. HEINEMAN, JR. WILLIAM HELMAN MARGARET KEANE MARIE-JOSEE KRAVIS, VICE CHAIR OF THE BOARD JAMIE C. NICHOLLS, VICE CHAIR OF THE BOARD (B) JAMES G. NIVEN BRUCE C. RATNER CLIFTON S. ROBBINS ALEXANDER T. ROBERTSON JAMES D. ROBINSON III VIRGINIA M. ROMETTY ALAN D. SCHNITZER STEPHEN C. SHERRILL PETER J. SOLOMON JOHN R. STRANGFELD SCOTT M. STUART, CHAIR OF THE BOARD CRAIG B. THOMPSON, M.D., BOARD MEMBER, PRESIDENT AND CHIEF EXECUTIVE OFFICER. EMPLOYEE, NOT INDEPENDENT BOARD MEMBER (C) SELWYN M VICKERS, M.D., PHD, BOARD MEMBER, PRESIDENT AND CHIEF EXECUTIVE OFFICER. EMPLOYEE, NOT INDEPENDENT BOARD MEMBER (D) DOUGLAS A. WARNER III, HONORARY CHAIR OF THE BOARD PETER A. WEINBERG 31 TOTAL BOARD MEMBERS 30 INDEPENDENT BOARD MEMBERS MEMORIAL HOSPITAL BOARD OF GOVERNING TRUSTEES: RICHARD I. BEATTIE, HONORARY CHAIRMAN OF THE BOARD IAN COOK, CHAIR OF THE BOARD (A) STANLEY F. DRUCKENMILLER ANTHONY B. EVNIN ROGER W. FERGUSON HENRY A. FERNANDEZ WILLIAM E. FORD RICHARD N. FOSTER STEPHEN FRIEDMAN ELLEN V. FUTTER LOUIS V. GERSTNER, JR. JONATHAN N. GRAYER BENJAMIN W. HEINEMAN, JR. WILLIAM HELMAN MARGARET KEANE MARIE-JOSEE KRAVIS JAMIE C. NICHOLLS, CHAIR OF THE BOARD (B) JAMES G. NIVEN BRUCE C. RATNER CLIFTON S. ROBBINS ALEXANDER T. ROBERTSON JAMES D. ROBINSON III VIRGINIA M. ROMETTY ALAN D. SCHNITZER STEPHEN C. SHERRILL PETER J. SOLOMON JOHN R. STRANGFELD SCOTT M. STUART CRAIG B. THOMPSON, M.D., BOARD MEMBER, CHIEF EXECUTIVE OFFICER, EMPLOYEE, NOT INDEPENDENT BOARD MEMBER (C) SELWYN M VICKERS, MD,PHD, BOARD MEMBER, PRESIDENT AND CHIEF EXECUTIVE OFFICER, EMPLOYEE, NOT INDEPENDENT BOARD MEMBER (D) DOUGLAS A. WARNER III PETER A. WEINBERG 31 TOTAL BOARD MEMBERS 30 INDEPENDENT BOARD MEMBERS SLOAN KETTERING INSTITUTE BOARD OF GOVERNING TRUSTEES: RICHARD I. BEATTIE IAN COOK STANLEY F. DRUCKENMILLER ANTHONY B. EVNIN ROGER W. FERGUSON HENRY A. FERNANDEZ WILLIAM E. FORD RICHARD N. FOSTER STEPHEN FRIEDMAN ELLEN V. FUTTER LOUIS V. GERSTNER, JR., HONORARY CHAIR OF THE BOARD JONATHAN N. GRAYER BENJAMIN W. HEINEMAN, JR. WILLIAM HELMAN MARGARET KEANE MARIE-JOSEE KRAVIS, CHAIR OF THE BOARD JAMIE C. NICHOLLS JAMES G. NIVEN BRUCE C. RATNER CLIFTON S. ROBBINS ALEXANDER T. ROBERTSON JAMES D. ROBINSON III VIRGINIA M. ROMETTY ALAN D SCHNITZER STEPHEN C. SHERRILL PETER J. SOLOMON JOHN R. STRANGFELD SCOTT M. STUART CRAIG B. THOMPSON, M.D., BOARD MEMBER, CHIEF EXECUTIVE OFFICER, EMPLOYEE, NOT INDEPENDENT BOARD MEMBER (C) SELWYN M VICKERS, MD, PHD. BOARD MEMBER, PRESIDENT AND CHIEF EXECUTIVE OFFICER, EMPLOYEE, NOT INDEPENDENT BOARD MEMBER (D) DOUGLAS A. WARNER III PETER A. WEINBERG 31 TOTAL BOARD MEMBERS 30 INDEPENDENT BOARD MEMBERS S.K.I. REALTY BOARD OF DIRECTORS: RICHARD I. BEATTIE LOUIS V. GERSTNER, JR. JAMES G. NIVEN, PRESIDENT CLIFTON S. ROBBINS SCOTT M. STUART, CHAIRMAN OF THE BOARD DOUGLAS A. WARNER III 6 TOTAL BOARD MEMBERS 6 INDEPENDENT BOARD MEMBERS GERSTNER GRADUATE SCHOOL BOARD OF TRUSTEES: RICHARD I. BEATTIE ELLEN V. FUTTER LOUIS V. GERSTNER, JR., CHAIR EMERITUS (A) MARIE-JOSEE KRAVIS ALAN D SCHNITZER, CHAIR OF THE BOARD (A) SCOTT M. STUART CRAIG B. THOMPSON, M.D. BOARD MEMBER, PRESIDENT, EMPLOYEE, NOT INDEPENDENT BOARD MEMBER (C) SELWYN M VICKERS MD, PHD, BOARD MEMBER, PRESIDENT AND CHIEF EXECUTIVE OFFICER, EMPLOYEE, NOT INDEPENDENT BOARD MEMBER (D) DOUGLAS A. WARNER III (A) 8 TOTAL BOARD MEMBERS 7 INDEPENDENT BOARD MEMBERS MSK INSURANCE U.S. BOARD OF DIRECTORS: DEBRA BERNS, EMPLOYEE, NOT AN INDEPENDENT BOARD MEMBER KATHRYN MARTIN, DIRECTOR AND SECRETARY, EMPLOYEE, NOT AN INDEPENDENT BOARD MEMBER STEPHEN C. SHERRILL, CHAIRMAN OF THE BOARD MARK SVENNINGSON, BOARD MEMBER AND PRESIDENT, EMPLOYEE, NOT INDEPENDENT BOARD MEMBER JEFFREY P. JOHNSON, BOARD MEMBER AND VICE PRESIDENT MICHAEL P HARRINGTON, EMPLOYEE, NOT AN INDEPENDENT BOARD MEMBER 6 TOTAL BOARD MEMBERS 2 INDEPENDENT BOARD MEMBERS MSKCC PROTON INC., BOARD OF DIRECTORS: SIMON POWELL MD., EMPLOYEE, NOT AN INDEPENDENT DIRECTOR MICHAEL HARRINGTON, EMPLOYEE, NOT AN INDEPENDENT DIRECTOR MARGARET BURKE, EMPLOYEE, NOT AN INDEPENDENT DIRECTOR 3 TOTAL DIRECTOR, 0 INDEPENDENT DIRECTORS (A) EFFECTIVE JUNE 2022 (B) UNTIL JUNE 2022 (C) UNTIL OCTOBER 2022 (D) EFFECTIVE OCTOBER 2022 |
| PART VII, SECTION B | AMOUNTS PAID TO INDEPENDENT CONTRACTORS INCLUDE AMOUNTS PAID TO SUBCONTRACTORS AS WELL AS REIMBURSABLE EXPENSES. PART XI RECONCILIATION OF NET ASSETS, OTHER NON-OPERATING (EXPENSE): CHANGE IN POSTRETIREMENT $ 140,114,000 OTHER NON-OPER EXPENSE (10,379,000) TOTAL $ 129,735,000 |
Schedule R IRS990ScheduleR
Id Disregarded Entities IdDisregardedEntitiesGrp
Disregarded Entity Name DisregardedEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PROSTATE CANCER CLINICAL TRIALS | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1275 YORK AVE | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10065 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 352506225 | EIN |
| Primary Activities | CANCER CARE | PrimaryActivitiesTxt |
| Legal Domicile State | DE | LegalDomicileStateCd |
| Total Income | $19,074,000 | TotalIncomeAmt |
| End Of Year Assets | $3,149,000 | EndOfYearAssetsAmt |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MSKCC | BusinessNameLine1Txt |
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (2 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Controlled OrganizationControlledOrganizationInd | Direct Controlling NADirectControllingNACd |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MEMORIAL MEDICAL CARE PC | |||||||||||
| 1275 YORK AVENUE | NEW YORK | NY | 10065 | 352491455 | CANCER CARE | NY | 501(C)3 | 10 | MSKCC | Yes (true) | |
| TRI-INSTITUTIONAL THERAPEUTICS DISC INST | |||||||||||
| 1300 YORK AVE | NEW YORK | NY | 10065 | 463673346 | MED RESEA EDU | DE | 509(A)(3) | 12E | Yes (true) | N/A | |
Id Related Org Txbl Partnership IdRelatedOrgTxblPartnershipGrp (34 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Predominant Income TypePredominantIncomeTypeTxt | Share Of Total IncomeShareOfTotalIncomeAmt | Share Of EOY AssetsShareOfEOYAssetsAmt | Disproportionate AllocationsDisproportionateAllocationsInd | UBI Code VUBICodeVAmt | General Or Managing PartnerGeneralOrManagingPartnerInd | OwnershipOwnershipPct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MEM INFECT DISEASE | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133278582 | HEALTH CARE | NY | MEM | RELATED | $2,816,016 | $0 | false | $0 | Yes (true) | 1.00000 |
| MEM MEDICAL CONSULT | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133278550 | HEALTH CARE | NY | MEM | RELATED | $10,868,351 | $0 | false | $0 | Yes (true) | 1.00000 |
| MEM SOLID TUMOR GRP | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133278578 | HEALTH CARE | NY | MEM | RELATED | $47,704,965 | $0 | false | $0 | Yes (true) | 1.00000 |
| MEM PULMONARY FUNC | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133304834 | HEALTH CARE | NY | MEM | RELATED | $4,928,298 | $0 | false | $0 | Yes (true) | 1.00000 |
| MEM CARDIOPULMONARY | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133278552 | HEALTH CARE | NY | MEM | RELATED | $5,623,677 | $0 | false | $0 | Yes (true) | 1.00000 |
| MSK RADIOLOGY GRP | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133375559 | HEALTH CARE | NY | MEM | RELATED | $78,255,556 | $0 | false | $0 | Yes (true) | 1.00000 |
| MEM NUCLEAR MED | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133278580 | HEALTH CARE | NY | MEM | RELATED | $10,018,171 | $0 | false | $0 | Yes (true) | 1.00000 |
| MEM RADIATION ONCOL | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133237927 | HEALTH CARE | NY | MEM | RELATED | $25,887,511 | $0 | false | $0 | Yes (true) | 1.00000 |
| MEM PATHOLOGY GRP | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133365998 | HEALTH CARE | NY | MEM | RELATED | $57,379,205 | $0 | false | $0 | Yes (true) | 1.00000 |
| MEM ANESTHESIOLOGY | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133367135 | HEALTH CARE | NY | MEM | RELATED | $67,418,786 | $0 | false | $0 | Yes (true) | 1.00000 |
| MEM PEDIATRICS GRP | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133346908 | HEALTH CARE | NY | MEM | RELATED | $10,352,522 | $0 | false | $0 | Yes (true) | 1.00000 |
| MEM NEUROLOGY GRP | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133399377 | HEALTH CARE | NY | MEM | RELATED | $14,662,023 | $0 | false | $0 | Yes (true) | 1.00000 |
| MEM PSYCHIATRY GRP | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133430629 | HEALTH CARE | NY | MEM | RELATED | $4,019,852 | $0 | false | $0 | Yes (true) | 1.00000 |
| MSK SURGERY GROUP | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 134010372 | HEALTH CARE | NY | MEM | RELATED | $184,940,977 | $0 | false | $0 | Yes (true) | 1.00000 |
| MSK HAUPPAUGE | ||||||||||||||
| 1275 YORK AVENUE | NY | NY | 10065 | 134059247 | HEALTH CARE | NY | MEM | RELATED | $5,772,737 | $0 | false | $0 | Yes (true) | 1.00000 |
| INTEGRATIVE MED | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 542092060 | HEALTH CARE | NY | MEM | RELATED | $2,240,274 | $0 | false | $0 | Yes (true) | 1.00000 |
| MSK-REGIONAL NETWK | ||||||||||||||
| 1275 YORK AVENUE | NY | NY | 10065 | 020594889 | HEALTH CARE | NY | MEM | RELATED | $22,732,574 | $0 | false | $0 | Yes (true) | 1.00000 |
| MSK BASKING RIDGE | ||||||||||||||
| 1275 YORK AVENUE | NY | NY | 10065 | 593801080 | HEALTH CARE | NY | MEM | RELATED | $19,043,156 | $0 | false | $0 | Yes (true) | 1.00000 |
| MEM URGENT CARE GRP | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 651263291 | HEALTH CARE | NY | MEM | RELATED | $7,893,695 | $0 | false | $0 | Yes (true) | 1.00000 |
| MEM CLN GENETICS | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 651263292 | HEALTH CARE | NY | MEM | RELATED | $910,042 | $0 | false | $0 | Yes (true) | 1.00000 |
| MEM DEVELOP CHEMO | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133278548 | HEALTH CARE | NY | MEM | RELATED | $5,811,207 | $0 | false | $0 | Yes (true) | 1.00000 |
| MSK CLINIC PRACTICE | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 510616510 | HEALTH CARE | NY | MEM | RELATED | $12,570,136 | $0 | false | $0 | Yes (true) | 1.00000 |
| MEM CLINICAL PHY | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133278556 | HEALTH CARE | NY | MEM | RELATED | $2,126,700 | $0 | false | $0 | Yes (true) | 1.00000 |
| MEM DERMATOLOGY GRP | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133278581 | HEALTH CARE | NY | MEM | RELATED | $8,590,503 | $0 | false | $0 | Yes (true) | 1.00000 |
| MEM ENDOCRINE GRP | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133278583 | HEALTH CARE | NY | MEM | RELATED | $4,754,474 | $0 | false | $0 | Yes (true) | 1.00000 |
| GASTROENTEROLOGY | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133278574 | HEALTH CARE | NY | MEM | RELATED | $10,182,130 | $0 | false | $0 | Yes (true) | 1.00000 |
| MEM HEMATOLOGYLYMP | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 133278575 | HEALTH CARE | NY | MEM | RELATED | $22,938,805 | $0 | false | $0 | Yes (true) | 1.00000 |
| MSK HARRISON | ||||||||||||||
| 1275 YORK AVENUE | NY | NY | 10065 | 300831483 | HEALTH CARE | NY | MEM | RELATED | $29,190,150 | $0 | false | $0 | Yes (true) | 1.00000 |
| MSK BERGEN | ||||||||||||||
| 1275 YORK AVENUE | NY | NY | 10065 | 611791803 | HEALTH CARE | NY | MEM | RELATED | $17,647,019 | $0 | false | $0 | Yes (true) | 1.00000 |
| MSK MONMOUTH | ||||||||||||||
| 1275 YORK AVE | NY | NY | 10065 | 300937486 | HEALTH CARE | NY | MEM | RELATED | $26,584,674 | $0 | false | $0 | Yes (true) | 1.00000 |
| MSK NASSAU | ||||||||||||||
| 1275 YORK AVENUE | NY | NY | 10065 | 611904151 | health care | NY | MEM | RELATED | $18,624,955 | $0 | false | $0 | Yes (true) | 1.00000 |
| RALPH LAUREN CENTER | ||||||||||||||
| 1275 YORK AVENUE | NY | NY | 10065 | 320577172 | health care | NY | MEM | RELATED | $439,483 | $0 | false | $0 | Yes (true) | 1.00000 |
| PANAKEIA ENERGY | ||||||||||||||
| 10000 MEMORIAL DR | HOUSTON | TX | 77024 | 800891961 | INVESTMENT | DE | MSK | EXCLUDED UNDER 512 | -$19,664 | $0 | false | false | ||
| BTS LIQUIDATING LLC | ||||||||||||||
| 1430 BROADWAY | NY | NY | 10018 | 262602952 | INVESTMWNT | NY | MSK | EXCLUDED UNDER 512 | -$76,775 | $129,602 | false | $0 | false | 0.80000 |
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp (3 entries)
| Direct Controlling NADirectControllingNACd | Address Line1ForeignAddress/AddressLine1Txt | CityForeignAddress/CityNm | CountryForeignAddress/CountryCd | Foreign PostalForeignAddress/ForeignPostalCd | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile Foreign CountryLegalDomicileForeignCountryCd | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Entity TypeEntityTypeTxt |
|---|---|---|---|---|---|---|---|---|
| CHARITABLE REMAINDER TRUSTS 196 | ||||||||
| N/A | ||||||||
| TWO SIGMA US ALL CAP EQUITY BATA CAYMEN | ||||||||
| 89 NEXUS WAY CAMANA BAY | GRAND CAYMAN | CJ | KY1-9007 | INVESTMENT | CJ | MSK | C | |
| AXAR OFFSHORE FUND LTD | ||||||||
| PO BOX 309 UGLAND HOUSE | GRAND CAYMAN | CJ | CJ KY1-1104 | INVESTMENT | CJ | MSK | c | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | false | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | false | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | false | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | false | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | false | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | false | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | false | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | false | SharingOfFacilitiesInd |
| Reimbursement Paid To Other Org | false | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | Yes (true) | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | false | TransferToOtherOrgInd |
| Transfer From Other Org | false | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp
Other Organization Name OtherOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MEMORIAL MEDICAL CARE PC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Transaction Type | Q | TransactionTypeTxt |
| Involved | $541,000 | InvolvedAmt |
| Method Of Amount Determination | Cost | MethodOfAmountDeterminationTxt |